var data={"specialtyName":"Authors and Editors in Hematology","contributorTypes":[{"name":"Editors-in-Chief","contributors":[{"name":"Richard A Larson, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Leukemia\n","Professor of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [leukemia (gilteritinib)]; Erytech [leukemia (eryaspase)]; Novartis [leukemia (nilotinib, ascininib)]; Daiichi Sankyo [leukemia (quizartinib)]; Celgene [leukemia (enasidenib)]. Consultant/Advisory Boards: Novartis [leukemia (imatinib, nilotinib)]; Ariad Data Safety Monitoring Board [leukemia (ponatinib)]; CVS/Caremark [leukemia (drug prior authorization program)]; Celgene Data Safety Monitoring Board [leukemia (azacitidine, durvalumab)]; Amgen [leukemia (blinatumomab)]; Astellas [leukemia (gilteritinib)]; Jazz [leukemia (CPX-351)]."},{"name":"Lawrence LK Leung, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Disorders of Hemostasis and Coagulation\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Stanley L Schrier, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Myeloproliferative Disorders; Red Blood Cell Disorders\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""}]},{"name":"Deputy Editors","contributors":[{"name":"Rebecca F Connor, MD","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Hematology"],"disclosure":""},{"name":"Alan G Rosmarin, MD","credentials":["Deputy Editor — Hematology\n","Professor of Medicine\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Jennifer S Tirnauer, MD","credentials":["Deputy Editor — Hematology"],"disclosure":""}]},{"name":"Section Editors","contributors":[{"name":"Nelson J Chao, MD","credentials":["Section Editor — Bone Marrow Transplantation\n","Professor of Medicine\n","Duke University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Jazz [GVHD (defibrotide)]; NIH [hematopoiesis]."},{"name":"Arnold S Freedman, MD","credentials":["Section Editor — Lymphoproliferative Disorders\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Kahr Therapeutics [SAB]. Other Financial Interest: Novartis [DMB (Ofatumumab)]; Bayer [DMB (Bayer 17833)]."},{"name":"Steven Kleinman, MD","credentials":["Section Editor — Transfusion Medicine\n","Clinical Professor of Pathology\n","University of British Columbia, Vancouver"],"disclosure":"Consultant/Advisory Boards: Cerus Corp [Pathogen reduction of blood components (Intercept Blood system)]. Equity Ownership/Stock Options: Cerus Corp."},{"name":"Timothy M Kuzel, MD, FACP","credentials":["Section Editor — Lymphoproliferative Disorders \n","Professor of Medicine, Rush University Medical Center\n","Chief, Division of Hematology/Oncology/Cell Therapy"],"disclosure":"Grant/Research/Clinical Trial Support: Seattle Genetics [CTCL (brentuximab vedotin)]; Kyowa [CTCL (anti CCR4 antibody)]; Celgene [CTCL (romidepsin)]; Esai [CTCL (denileukin diftitox)]. Speaker's Bureau: Celgene [CTCL (romidepsin)]. Consultant/Advisory Boards: Amgen [CTCL and melanoma]; Eisai [CTCL and renal cell CA]."},{"name":"Robert A Kyle, MD","credentials":["Section Editor — Plasma Cell Disorders\n","Professor of Medicine\n","Mayo Medical School"],"disclosure":"Consultant/Advisory Boards: Celgene Disease Monitoring Committee [Dysproteinemias (lenalidomide, pomalidomide)]; Bristol-Myers Squibb Independent Monitoring Committee [Dysproteinemias (elotuzumab)]; Onyx Pharma (Amgen) Data Monitoring Committee [Dysproteinemias (carfilzomib)]; Pharmacyclics Data Safety Monitoring Board [Dysproteinemias (ibrutinib)]. Other Financial Interest: Pfizer [Lecture on therapy of multiple myeloma, made comments concerning a new Pfizer product and received an honorarium]."},{"name":"Richard A Larson, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Leukemia\n","Professor of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [leukemia (gilteritinib)]; Erytech [leukemia (eryaspase)]; Novartis [leukemia (nilotinib, ascininib)]; Daiichi Sankyo [leukemia (quizartinib)]; Celgene [leukemia (enasidenib)]. Consultant/Advisory Boards: Novartis [leukemia (imatinib, nilotinib)]; Ariad Data Safety Monitoring Board [leukemia (ponatinib)]; CVS/Caremark [leukemia (drug prior authorization program)]; Celgene Data Safety Monitoring Board [leukemia (azacitidine, durvalumab)]; Amgen [leukemia (blinatumomab)]; Astellas [leukemia (gilteritinib)]; Jazz [leukemia (CPX-351)]."},{"name":"Lawrence LK Leung, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Disorders of Hemostasis and Coagulation\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Andrew Lister, MD, FRCP, FRCPath, FRCR","credentials":["Section Editor — Lymphoproliferative Disorders\n","Professor of Medical Oncology\n","St. Bartholomew's Hospital, London"],"disclosure":"Consultant/Advisory Boards: Celgene [malignant lymphoma], Pfizer [Lymphoma (anti-CD20 biosimilars)], Gilead (data monitoring committee) [CLL, indolent lymphoma (idelalisib [CAL 101])], Roche (data monitoring committee) [Indolent lymphoma (obinutuzumab [GA101])], Millennium/Takeda (data monitoring committee) [Hodgkin lymphoma (brentuximab vedotin)]; Merck (pembrolizumab). Equity Ownership/Stock Options (Spouse also): GSK; Johnson & Johnson; AstraZeneca; Novartis; Pfizer; Hikma Pharma."},{"name":"Bob Lowenberg, MD, PhD","credentials":["Section Editor — Leukemia\n","Professor and Chairman, Department of Hematology\n","Erasmus University Medical Center, The Netherlands"],"disclosure":"Consultant/Advisory Boards: Clear Creek Bio [Acute myeloid leukemia (Brequinar)]; Celgene [Acute myeloid leukemia (Enasidenib)]; AGIOS [Acute myeloid leukemia (Ivosidenib)]; Astellas [Acute myeloid leukemia (Gilteritinib)]; F. Hoffmann-La Roche; AbbVie [Acute myeloid leukemia (Venetoclax)]."},{"name":"Pier Mannuccio Mannucci, MD","credentials":["Section Editor — Disorders of Hemostasis and Coagulation\n","Professor of Internal Medicine, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center\n","University of Milan, Italy"],"disclosure":"Speaker's Bureau: Shire, Bayer, Grifols, Kedrion Biopharma, Novo Nordisk, LFB [hemophilia, coagulation disorders]. Consultant/Advisory Boards: Bayer, Kedrion Biopharma [hemophilia, coagulation disorders]."},{"name":"William C Mentzer, MD","credentials":["Section Editor — Red Cell Disorders\n","Professor of Pediatrics\n","University of California, San Francisco"],"disclosure":"Equity Ownership/Stock Options: Johnson & Johnson [Anemia (Erythropoietin)]."},{"name":"Robert S Negrin, MD","credentials":["Section Editor — Bone Marrow Transplantation\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Immuno-oncology]; Jazz Pharmaceuticals [Veno-occlusive disease (Defibrotide)]; Cell Source [Cellular therapy]; Magenta Pharmaceuticals [Transplantation]. Equity Ownership/Stock Options: Concentrx [Cellular immunotherapy]; Magenta Pharmaceuticals [Transplantation]; Cell Source [Cellular therapy]. Other Financial Interest: American Society of Hematology [Editor in Chief of \"Blood Advances\"]."},{"name":"Peter Newburger, MD","credentials":["Section Editor — White Blood Cell Disorders\n","Ali and John Pierce Professor of Pediatric Hematology/Oncology\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Julie R Park, MD","credentials":["Section Editor — Lymphoma; Pediatric Oncology\n","Professor of Pediatrics\n","University of Washington"],"disclosure":""},{"name":"Stanley L Schrier, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Myeloproliferative Disorders; Red Blood Cell Disorders\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Arthur J Silvergleid, MD","credentials":["Section Editor — Transfusion Medicine\n","Affiliate Associate Professor, Department of Pathology and Cell Biology\n","University of South Florida, College of Medicine\n","Medical Director, OneBlood, Inc."],"disclosure":""}]},{"name":"Editorial Assistants","contributors":[{"name":"Michael F Bottari, BA","credentials":["Editorial Assistant — UpToDate"],"disclosure":""}]},{"name":"Authors","contributors":[{"name":"Vikki M Abrahams, PhD","credentials":["Associate Professor \n","Yale University School of Medicine"],"disclosure":""},{"name":"Charles S Abrams, MD","credentials":["Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Steven B Abramson, MD","credentials":["Professor of Medicine and Pathology\n","New York University School of Medicine"],"disclosure":""},{"name":"M Jacob Adams, MD, MPH","credentials":["Associate Professor (retired)\n","University of Rochester School of Medicine and Dentistry"],"disclosure":""},{"name":"Anjali S Advani, MD","credentials":["Director, Inpatient Leukemia Unit\n","Associate Professor, Cleveland Clinic Lerner College of Medicine\n","Staff, Department of Hematology/Oncology\n","Taussig Cancer Institute, The Cleveland Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen (ALL [blinotumomab]); Pfizer (ALL [inotuzumab]). Consultant/Advisory Boards: Pfizer (ALL [inotuzumab])."},{"name":"Maria I Aguilar, MD","credentials":["Associate Professor of Neurology\n","Mayo Clinic Arizona"],"disclosure":""},{"name":"Vivek N Ahya, MD","credentials":["Assistant Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Wei Ai, MD, PhD","credentials":["Clinical Associate Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"William C Aird, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Tarek Alhamad, MD, MS, FACP, FASN","credentials":["Assistant Professor of Medicine\n","Washington University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Mallinckrodt [Nephrotic syndrome (ACTH gel)]; Angion [BB3 analogue]. Speaker's Bureau: Veloxis [Immunosuppression medications (Tacrolimus XR)]. Consultant/Advisory Board: Veloxis [Immunosuppression medications (Tacrolimus XR)]."},{"name":"Harrison Alter, MD, MS, FACEP","credentials":["Attending Physician\n","Highland Hospital – Alameda Health System, Oakland, California\n","Associate Clinical Professor of Medicine, Division of Emergency Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Richard F Ambinder, MD, PhD","credentials":["James B Murphy Professor of Oncology\n","Johns Hopkins School of Medicine"],"disclosure":"Consultant/Advisory Boards: Bristol-Myers Squibb [Cancer drugs (Checkpoint inhibitors)]; Viracta [Cancer drugs (Therapeutic trial for unlicensed drug)]; Cellgenesis [Cancer drugs (Imides, proteasome inhibitors)]; National Comprehensive Cancer Network [Hodgkin lymphoma, HIV malignancy)]."},{"name":"Karl E Anderson, MD, FACP","credentials":["Professor\n","The University of Texas Medical Branch"],"disclosure":"Grant/Research/Clinical Trial Support: Alnylam Pharmaceuticals [Acute porphyrias (RNAi therapy)]; Recordati Rare Disease [Acute porphyrias (Hemin)]; Mitsubishi Tanabe Pharma America [Protoporphyria]. Consultant/Advisory Boards: Alnylam Pharmaceuticals [Acute porphyrias (RNAi therapy)]; Recordati Rare Disease [Acute porphyrias (Hemin)]; Mitsubishi Tanabe Pharma America [Protoporphyria]; Moderna Therapeutics [Acute porphyrias]."},{"name":"Emanuele Angelucci, MD","credentials":["Head, Hematology and Transplant Unit\n","San Martino Hospital"],"disclosure":""},{"name":"Stephen M Ansell, MD, PhD","credentials":["Professor of Medicine, Division of Hematology\n","Mayo Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol Myers Squibb, Merck [immune checkpoint inhibitors (nivolumab, pembrolizumab)]."},{"name":"Joseph H Antin, MD","credentials":["Professor of Medicine, Harvard Medical School\n","Chief, Stem Cell Transplantation Program, Dana-Farber/Brigham and Women’s Cancer Center"],"disclosure":""},{"name":"Gerald B Appel, MD","credentials":["Section Editor — Glomerular Diseases\n","Professor of Medicine\n","Columbia University College of Physicians and Surgeons"],"disclosure":"Grant/Research/Clinical Trial Support: Regulus Therapeutics [Alport syndrome (RG-012, for injection)]; Bristol-Myers Squibb [Focal Segmental Glomerulosclerosis (Abatacept)]; Achillion [C3 Glomerulopathies (ACH-0144471, tablets)]; EMD Serono [Immunoglobulin A nephropathy (Atacicept)]; Reatta [Alport syndrome (Bardoxolone)]; Mallinkrodt [Focal Segmental Glomerulosclerosis (Corticotropin)]; Chemocentryx [C3 Glomerulopathies (Avacopan)]; Chemocentryx [Anti-Neutrophil Cytoplasmic Antibody Vasculitis (Avacopan)]. Speaker's Bureau: Genentech [Vasculitis (Rituximab)]; Sanofi [Side effects (Alemtuzumab)]. Consultant/Advisory Boards: Genentech; Takeda Pharmaceuticals; Bristol-Myers Squibb; Mallinckrodt Pharmaceuticals; EMD Serono; Merck; Pfizer; Genzyme-Sanofi; Omeros; Achillion Pharmaceuticals; Ionis; Reatta; Chemocentryx [Immunosuppressives (Drugs under development for immunosuppression)]."},{"name":"Donald M Arnold, MD, MSc","credentials":["Associate Professor, Department of Medicine\n","McMaster University\n","Canadian Blood Services"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [ITP (eltrombopag)]; Amgen [ITP (romiplostim)]; Bristol Meyers Squibb [ITP (investigational new drug)]; Rigel [ITP (fostamatinib)]. Consultant/Advisory Boards: Amgen [ITP (romiplostim)]; Novartis [ITP (eltrombopag)]; Rigel [ITP (fostamatinib)]; UCB [ITP (investigational new drug)]; Dova [ITP (investigational new drug)]."},{"name":"Jon C Aster, MD","credentials":["Professor of Pathology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Regeneron [Hematologic malignancies (Notch inhibitors)]; Lilly [Hematologic malignancies (Notch inhibitors)]; Cellestia [Hematologic malignancies (Notch inhibitors)]; Anastasis [Hematologic malignancies (Notch inhibitors)]. Equity Ownership/Stock Options: Cellestia; Anastasis."},{"name":"John P Atkinson, MD","credentials":["Samuel B Grant Professor of Medicine\n","Professor of Molecular Microbiology\n","Chief, Division Rheumatology\n","Washington University School of Medicine"],"disclosure":""},{"name":"Michael Auerbach, MD, FACP","credentials":["Clinical Professor of Medicine\n","Georgetown University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AMAG Pharmaceuticals; Pharmacosmos [Restless legs syndrome, iron deficiency of pregnancy (Ferumoxytol, low molecular weight iron dextran)]. Consultant/Advisory Boards: AMAG; Pharmacosmos; Luitpold/American Regent [Moderate to severe iron deficiency (Low molecular weight iron dextran)]."},{"name":"Michael Avidan, MD","credentials":["Section Editor — Surgical Critical Care\n","Professor of Anesthesiology and Surgery\n","Washington University School of Medicine"],"disclosure":""},{"name":"John S Axford, DSc, MD, FRCP, FRCPCH","credentials":["Section Editor — Scleroderma\n","Emeritus Professor of Rheumatology\n","St George's University of London"],"disclosure":""},{"name":"Bruce R Bacon, MD","credentials":["Professor of Internal Medicine\n","Saint Louis University School of Medicine"],"disclosure":""},{"name":"Zuhair K Ballas, MD","credentials":["Professor of Medicine\n","University of Iowa"],"disclosure":"Consultant/Advisory Boards: Immune Deficiency Foundation [Counseling for immunodeficiency patients and clinicians]; Checkmate Pharma [CpG in tumor immunotherapy (Products in trial)]."},{"name":"Mark Ballow, MD","credentials":["Professor of Pediatrics\n","All Children’s Hospital\n","University of South Florida School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring [Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial (Immunoglobulin)]; Shire [Immunoglobulin trial (Immunoglobulin)]. Speaker's Bureau: Shire [Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial (Immunoglobulin)]. Consultant/Advisory Boards: Grifols [Immunodeficiency (Immunoglobulin)]; CSL Behring [Immunodeficiency (Immunoglobulin)]; Shire [Immunodeficiency (Immunoglobulin)]. Other Financial Interest (Data Safety Monitoring Boards): Prometic; CSL Behring; Green Cross [Immunoglobulin]."},{"name":"Rasheed A Balogun, MD","credentials":["Professor of Medicine\n","University of Virginia"],"disclosure":""},{"name":"Subhas Banerjee, MD","credentials":["Director of Endoscopy\n","Associate Professor of Medicine\n","Stanford University Medical Center"],"disclosure":""},{"name":"Tracy Batchelor, MD, MPH","credentials":["Giovanni Armenise Professor of Neurology\n","Harvard Medical School"],"disclosure":"Grant/Research Support: Pfizer [Glioblastoma]. Consultant/Advisory Boards: Merck [Glioblastoma (temozolomide)]; Proximagen/Upsher [Glioblastoma]; Roche [Glioblastoma (rituximab)]; Oxigene [Glioblastoma]; Cavion [Glioblastoma]; Accerta [Lymphoma]; Amgen [Glioblastoma]; Genomicare [Brain tumors (diagnostic testing)]. Other Financial Interest: Oakstone Publishing; Champions Biotechnology; Imedex [Neuro-Oncology CME/Education (Educational Material)]."},{"name":"Kenneth A Bauer, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Janssen Pharmaceuticals [Anticoagulation (Rivaroxaban)]; Pfizer [Anticoagulation (Apixaban)]."},{"name":"Richard C Becker, MD","credentials":["Mabel Stearns Stonehill Endowed Professor of Medicine\n","Chief, Division of Cardiovascular Health and Disease\n","University of Cincinnati College of Medicine\n","Director and Physician-in-Chief\n","Heart, Lung, and Vascular Institute\n","University of Cincinnati/UC Health"],"disclosure":"Consultant/Advisory Boards: Portola; Janssen; Ionis; Akcea Therapeutics."},{"name":"Robert M Bennett, MD, FRCP, MACR","credentials":["Professor of Medicine\n","Oregon Health & Science University"],"disclosure":""},{"name":"Edward J Benz, Jr, MD","credentials":["Richard and Susan Smith Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Deciphera Pharmaceuticals, Advantagene, Knowledge to Practice [Board of Directors]. Equity Ownership/Stock Options: Deciphera; Advantagene; Knowledge to Practice [Stock options]. Equity Ownership/Stock Options (Spouse): Multiple pharma company stocks held in trust [Thalassemia (Desferioxamine)]."},{"name":"James R Berenson, MD","credentials":["Medical and Scientific Director\n","Institute for Myeloma and Bone Cancer Research"],"disclosure":""},{"name":"Nancy Berliner, MD","credentials":["Professor of Medicine\n","Harvard Medical School\n","H. Franklin Bunn Professor of Hematology and Chief, Division of Hematology \n","Brigham and Women's Hospital"],"disclosure":""},{"name":"Jeffrey S Berns, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Dialysis\n","Professor of Medicine\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Amgen [Clinical Trial EC (Darbepoetin)]."},{"name":"Caroline Bérubé, MD","credentials":["Clinical Associate Professor of Medicine (Hematology)\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Mark Bilsky, MD","credentials":["Attending Neurologic Surgeon\n","Memorial Sloan-Kettering Cancer Center\n","Professor Neurologic Surgery\n","Weill Medical College of Cornell University"],"disclosure":""},{"name":"Donald B Bloch, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Almut Böer-Auer, MD","credentials":["Director of Academics, Dermatologikum Hamburg\n","Lecturer, Westfälischen Wilhelms-Universität Münster"],"disclosure":""},{"name":"Jeffrey A Bogart, MD","credentials":["Professor & Chair\n","Department of Radiation Oncology\n","Upstate Medical University"],"disclosure":""},{"name":"Francisco A Bonilla, MD, PhD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Associate Professor of Pediatrics\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Charles River Associates International (Germany) GmbH [Consultant(Genetics of immunodeficiency)]; Grand Rounds Health [Consultant(Patient care)]; Green Cross, Parexel [DSM(Immunoglobulin therapy)]; Guidepoint Global Advisors [Consultant(General immunodeficiency)]; Health Resources Services Administration/HHS [Consultant(Vaccine injury)]; Immune Deficiency Foundation [Consultant(Patient care / Advisory board)]; Louis August Jonas Foundation [Board Member]; Sarepta [Consultant(Biologic therapy)]."},{"name":"Peter A L Bonis, MD","credentials":["Chief Medical Officer of Clinical Effectiveness (UpToDate, Clinical Drug Information, and Emmi Solutions)\n","Deputy Editor — Gastroenterology/Hepatology\n","Adjunct Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Susan E Boruchoff, MD","credentials":["Professor of Medicine\n","Robert Wood Johnson Medical School"],"disclosure":""},{"name":"Sylvia S Bottomley, MD","credentials":["Professor of Medicine\n","The University of Oklahoma College of Medicine"],"disclosure":""},{"name":"Beth A Bouchard, PhD","credentials":["Assistant Professor of Biochemistry\n","The University of Vermont"],"disclosure":""},{"name":"Daniel C Brennan, MD, FACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Renal Transplantation\n","Professor of Medicine\n","Medical Director and Co-Director of the Comprehensive Transplant Center, Department of Internal Medicine, Division of Nephrology\n","Johns Hopkins Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion; CareDx; Oxford Immunotech; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, delayed graft function, immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, antithymocyte globulin)]. Speaker's Bureau: Alexion; Sanofi; Novartis; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, valganciclovir, antithymocyte globulin)]. Consultant/Advisory Boards: Alexion; Sanofi; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus, antithymocyte globulin)]."},{"name":"Robert A Brodsky, MD","credentials":["Professor of Medicine and Oncology\n","Johns Hopkins University"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion, Apellis [PNH (eculizumab)]; Apellis [PNH].  Consultant/Advisory Boards: Alexion, Achillion, Apellis [PNH]."},{"name":"Jennifer R Brown, MD, PhD","credentials":["Associate Professor\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead; Verastem [CLL]. Consultant/Advisory Boards: Pharmacyclics; Infinity; Janssen; Celgene; Roche/Genentech; Gilead [CLL (Ibrutinib, IPI-145, lenalidomide, obinutuzumab, idelalisib)]; AbbVie [CLL (Venetoclax)]; Astra-Zeneca [CLL (Acalabrutinib)]."},{"name":"Carlo Brugnara, MD","credentials":["Professor\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Pfizer [sickle cell anemia (senicapoc)]."},{"name":"Glenn J Bubley, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"James D Burner, MD","credentials":["Associate Professor of Pathology\n","Medical Director of Transfusion Services\n","UT Southwestern Medical Center"],"disclosure":"Consultant/Advisory Boards: Grifols [Immunohematology (Blood bank instruments)]."},{"name":"Allison E Burnett, PharmD, PhC, CACP","credentials":["Antithrombosis Stewardship Pharmacist\n","University of New Mexico Hospital\n","Clinical Assistant Professor\n","University of New Mexico College of Pharmacy"],"disclosure":""},{"name":"Arthur L Burnett, MD, MBA, FACS","credentials":["Patrick C. Walsh Distinguished Professor of Urology, Cellular and Molecular Medicine\n","Johns Hopkins Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Endo Pharmaceutical [mechanisms of priapism]; Pfizer [mechanisms of priapism]; National Institutes of Health [mechanisms of priapism]; Auxilium [mechanisms of priapism]; American Medical Systems [mechanisms of priapism]; Coloplast [mechanisms of priapism]; Vivus [mechanisms of priapism]; Acorda Therapeutics [mechanisms of priapism]; New England Research Institute [mechanisms of priapism]; Medispec [mechanisms of priapism]. Consultant/Advisory Boards: Reflexonic LLC [mechanisms of priapism]; Genomic Health Inc [mechanisms of priapism]."},{"name":"Matthew E Call, PhD","credentials":["Head of Laboratory, Structural Biology Division\n","The Walter and Eliza Hall Institute of Medical Research\n","Department of Medical Biology\n","The University of Melbourne"],"disclosure":""},{"name":"Clara Camaschella, MD","credentials":["Professor of Internal Medicine\n","Vita-Salute University and San Raffaele Scientific Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Vifor Pharma [Iron deficiency anemia (Use of ferric carboxymaltose)]."},{"name":"Michael Camilleri, MD","credentials":["Professor of Medicine, Pharmacology, and Physiology\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Rhythm Pharmaceuticals [Gastroparesis (RM-131)]; Takeda [Gastroparesis (TAK954)]; Novartis [Bile acid diarrhea (LJN452)]; AstraZeneca [Naloxegol effects on GI transit in health]; NGM Biopharma [Functional constipation (NGM282)]; Allergan [Bile acid malabsorption (Eluxadoline)]; ELIRA [Gastric emptying (T6 dermatome device)]; Vibrant [Vibrating capsule and constipation]. Consultant/Advisory Boards: Ironwood [Gastroparesis (Advisory Board on treatment and management approaches)]; Allergan [Diabetic gastroparesis]; AstraZeneca [Naloxegol and OIC]; ElobixAB [Bile acid inhibitor for constipation]; Shire [Prucalopride for constipation]; Takeda [Clinical trials]; Theravance [50-HT4 receptor agonists and PAMORA]; Bio-kier [Obesity, diabetes]; OUTPOST medicine [OP687 for IBS]. Equity Ownership/Stock Options: Dignify Therapeutics; Enterin."},{"name":"George P Canellos, MD","credentials":["Editor-in-Chief — Oncology\n","Section Editor — Miscellaneous Tumors\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Jeffrey L Carson, MD","credentials":["Provost, New Brunswick Rutgers Biomedical Health Sciences, Rutgers University\n","Richard C Reynolds Chair in General Internal Medicine\n","Distinguished Professor of Medicine\n","Rutgers Robert Wood Johnson Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Terumo BCT [Pathogen inactivation]; NIH [Transfusion thresholds in myocardial infarction]."},{"name":"Mariana C Castells, MD, PhD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Daniel Catovsky, MD, DSc (Med), FRCPath, FRCP, FMedSci","credentials":["Emeritus Professor of Haematology\n","Institute of Cancer Research, Sutton, Surrey, UK"],"disclosure":""},{"name":"Emi H Caywood, MD","credentials":["Director, Blood and Bone Marrow Transplant\n","Nemours/Alfred I duPont Hospital for Children"],"disclosure":""},{"name":"Nelson J Chao, MD","credentials":["Section Editor — Bone Marrow Transplantation\n","Professor of Medicine\n","Duke University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Jazz [GVHD (defibrotide)]; NIH [hematopoiesis]."},{"name":"W Winn Chatham, MD","credentials":["Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":""},{"name":"Athena M Cherry, PhD","credentials":["Professor of Pathology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Jane E Churpek, MD","credentials":["Assistant Professor, Section of Hematology/Oncology\n","The University of Chicago"],"disclosure":""},{"name":"Mark W Clemens, MD, FACS","credentials":["Associate Professor, Plastic Surgery\n","MD Anderson Cancer Center, University of Texas"],"disclosure":""},{"name":"Thomas D Coates, MD","credentials":["Professor of Pediatrics and Pathology\n","University of Southern California School of Medicine"],"disclosure":"Consultant/Advisory Boards: Apopharma [Iron overload]; Celgene [Thalassemia]."},{"name":"Wilson S Colucci, MD","credentials":["Section Editor — Heart Failure\n","Professor of Medicine\n","Boston University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Novartis [Heart failure (Valsartan, sacubitril/valsartan)], Merck [Heart failure (Enalapril)], Amgen [Heart failure (Ivabradine)]."},{"name":"Rebecca F Connor, MD","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Hematology"],"disclosure":""},{"name":"Louis S Constine, MD","credentials":["Professor of Radiation Oncology and Pediatrics\n","Vice Chair\n","University of Rochester Medical Center"],"disclosure":""},{"name":"Timothy P Cooley, MD","credentials":["Associate Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Todd M Cooper, DO","credentials":["Associate Professor of Pediatrics \n","University of Washington\n","Director - Leukemia Program\n","Seattle Children's Cancer and Blood Disorders Center"],"disclosure":""},{"name":"Scott J Cotler, MD","credentials":["Professor of Medicine\n","Director, Division of Hepatology\n","Loyola University Medical Center"],"disclosure":""},{"name":"Steven Coutre, MD","credentials":["Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Kendall P Crookston, MD, PhD","credentials":["Professor, Departments of Pathology and Medicine\n","University of New Mexico School of Medicine\n","Medical Director, Transfusion Medicine and Therapeutic Apheresis, University of New Mexico Hospitals\n","Medical Director, TriCore Reference Laboratories, Albuquerque, NM"],"disclosure":""},{"name":"Sheila E Crowe, MD, FRCPC, FACP, FACG, AGAF","credentials":["Professor of Medicine\n","University of California, San Diego"],"disclosure":""},{"name":"Mark Crowther, MD, MSc","credentials":["Professor of Medicine and Pathology & Molecular Medicine\n","St Joseph’s Hospital and McMaster University"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer; Heart & Stroke Foundation; Leo [Anticoagulation]. Consultant/Advisory Boards: Bayer; Daiichi [Anticoagulation]; Portola [Anticoagulation reversal]; Shinogi [Antiplatelet therapy]. Other Financial Interests: Alexion [Thrombosis (Preparation of education materials and/or presentations)]; Boehringer Ingelheim [Anticoagulation reversal, anticoagulation (Preparation of educational materials and/or presentations)]; Bayer; Pfizer [Anticoagulation (Preparation of educational materials and/or presentations)]; Bayer [Thrombosis, anticoagulant drugs (Medicolegal activities)]."},{"name":"Christopher P Crum, MD","credentials":["Department of Pathology\n","Brigham and Women's Hospital"],"disclosure":""},{"name":"Adam Cuker, MD, MS","credentials":["Assistant Professor of Medicine, Assistant Professor of Pathology & Laboratory Medicine\n","Perelman School of Medicine University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Biogen-Idec, Spark Therapeutics, T2 Biosystems, Shire Pharmaceuticals. Consultant/Advisory Boards: Biogen-Idec, Diagnostica Stago."},{"name":"Corey Cutler, MD, MPH, FRCP(C)","credentials":["Associate Professor of Medicine \n","Harvard Medical School\n","Medical Director \n","Bone Marrow Transplant Survivors Clinic\n","Division of Hematologic Malignancies\n","Dana-Farber Cancer Institute"],"disclosure":""},{"name":"Donald Cutlip, MD","credentials":["Section Editor — Interventional Cardiology\n","Professor of Medicine\n","Harvard Medical School\n","Beth Israel Deaconess Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Boston Scientific [Transcatheter aortic valve; coronary artery stent]; CeloNova [coronary artery stent]."},{"name":"Nicholas Dainiak, MD, FACP","credentials":["Clinical Professor, Department of Therapeutic Radiology\n","Yale University School of Medicine\n","Medical and Technical Director\n","Radiation Emergency and Assistance Center (REAC/TS)"],"disclosure":""},{"name":"Timothy A Damron, MD","credentials":["Vice-Chair and David G. Murray Endowed Professor of Orthopedic Surgery\n","SUNY Upstate Medical University"],"disclosure":"Grant/Research/Clinical Trial Support: Stryker [Vitoss bone graft subsitute (Vitoss); Revision total joint clinical trial (Triathlon revision total knees)]; Wright Medical [Prodense bone graft substitute (Prodense)]."},{"name":"Matthew S Davids, MD, MMSc","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Claire Dearden, MD, BSc, FRCP, FRCPath","credentials":["Consultant Haematologist\n","The Royal Marsden Hospital and Institute of Cancer Research, London"],"disclosure":"Consultant/Advisory Boards: Roche [B-PLL (Rituximab)]; Gilead [B-PLL (Idelalisib)]; Janssen [B-PLL (Ibrutinib)]; Sanofi [T-PLL (Alemtuzumab)]."},{"name":"Michael R DeBaun, MD, MPH","credentials":["Professor of Pediatrics and Internal Medicine\n","Vanderbilt University School of Medicine"],"disclosure":""},{"name":"H Joachim Deeg, MD","credentials":["Professor of Medicine, University of Washington\n","Member, Fred Hutchinson Cancer Research Center"],"disclosure":"Grant/Research/Clinical Trial Support: Baxalta/Shire\t[GVHD (Alpha 1 anti-trypsin)]. Consultant/Advisory Boards: Medac [transplantation (treosulfan)]."},{"name":"Angela Dispenzieri, MD","credentials":["Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine, and Pathology\n","Mayo Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Celgene, Takeda, Alnylam, Janssen, Prothena (tafamidis, lenalidomide, pomalidomide, ixazomib, bortezomib, NEOD001]."},{"name":"Gary V Doern, MD","credentials":["Emeritus Professor of Pathology\n","University of Iowa College of Medicine"],"disclosure":""},{"name":"James D Douketis, MD, FRCPC, FACP, FCCP","credentials":["Professor, Department of Medicine\n","McMaster University"],"disclosure":"Consultant/Advisory Boards: Bayer [Venous thromboembolic disease, atrial fibrillation (Rivaroxaban)]; Sanofi [Venous thromboembolic disease (Enoxaparin)]; Leo Pharma [Venous thromboembolic disease (Tinzaparin)]; Janssen [Venous thromboembolic disease, atrial fibrillation (Rivaroxaban)]."},{"name":"Reed E Drews, MD","credentials":["Section Editor — Complications of Cancer\n","Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Jarrod A Dudakov, PhD","credentials":["Assistant Member, Program in Immunology\n","Clinical Research Division\n","Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"Christine N Duncan, MD","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Olive Eckstein, MD","credentials":["Assistant Professor, Pediatric Hematology-Oncology\n","Histiocytosis & Lymphoma Team\n","Texas Children's Cancer Center/Hematology Service \n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Abcam [hemophagocytic lymphohistiocytosis (anti-interferon gamma antibody)]."},{"name":"Keith Elkon, MD","credentials":["Mannik-Henderson Professor of Medicine\n","Head, Division of Rheumatology\n","University of Washington"],"disclosure":""},{"name":"Michael Emmett, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Chief of Internal Medicine\n","Baylor University Medical Center"],"disclosure":"Consultant/Advisory Boards: ZS Pharma [Treatment of hyperkalemia (Potassium binder, zirconium silicate)]."},{"name":"Uta Erdbruegger, MD","credentials":["Associate Professor of Medicine\n","University of Virginia"],"disclosure":""},{"name":"Doruk Erkan, MD, MPH","credentials":["Associate Attending Rheumatologist, Hospital for Special Surgery\n","Associate Professor of Medicine, Weill Cornell Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Lupus Clinical Trials Consortium; GlaxoSmithKline [Lupus (Belimumab)]; EMD Serono [lupus]; National Institutes of Health [Antiphospholipid syndrome]; Hospital for Special Surgery Medical Education Academy [Antiphospholipid syndrome]. Consultant/Advisory Boards: GSK (lupus); Ablynx (Antiphospholipid Syndrome)."},{"name":"Elihu H Estey, MD","credentials":["Professor\n","University of Washington School of Medicine"],"disclosure":""},{"name":"Zeev Estrov, MD","credentials":["Professor of Medicine\n","University of Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte. Consultant/Advisory Boards: Incyte."},{"name":"Amos Etzioni, MD","credentials":["Professor Emeritus of Pediatrics and Immunology\n","The Rappaport Faculty of Medicine, Technion, Haifa"],"disclosure":""},{"name":"Ronald J Falk, MD","credentials":["Nan and Hugh Cullman Eminent Professor of Nephrology\n","Chair, Department of Medicine\n","Director, UNC Kidney Center\n","University of North Carolina-Chapel Hill"],"disclosure":""},{"name":"Harrison W Farber, MD","credentials":["Professor of Medicine\n","Boston University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Actelion [Pulmonary hypertension (Bosentan, macitentan, selexipag, epoprostenol)]; Gilead [Pulmonary hypertension (Ambrisentan)]; United Therapeutics [Pulmonary hypertension (Treprostinil)]; Bayer [Pulmonary hypertension (Epoprostenol, riociguat)]; Eli Lilly [Pulmonary hypertension (Tadalafil)]. Speaker's Bureau: Actelion [Pulmonary hypertension (Bosentan, macitentan, selexipag, epoprostenol)]; Bayer [Pulmonary hypertension (Epoprostenol, riociguat)]; Gilead [Pulmonary hypertension (Ambrisentan)]. Consultant/Advisory Boards: Actelion [Pulmonary hypertension (Bosentan, macitentan, selexipag, epoprostenol)]; Bayer [Pulmonary hypertension (Epoprostenol, riociguat)]; Gilead [Pulmonary hypertension (Ambrisentan)]; United Therapeutics [Pulmonary hypertension (Treprostinil)]; Bellerophon [Pulmonary hypertension]; Eli Lilly [Pulmonary hypertension (Tadalafil)]."},{"name":"William P Fay, MD","credentials":["Professor of Internal Medicine \n","Director, Division of Cardiovascular Medicine \n","University of Missouri"],"disclosure":""},{"name":"Robert L Ferrer, MD, MPH","credentials":["Professor, Department of Family and Community Medicine\n","University of Texas Health Science Center at San Antonio"],"disclosure":""},{"name":"Fernando C Fervenza, MD, PhD","credentials":["Section Editor — Glomerular Diseases \n","Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial support: Genentech [Membranous nephropathy, Fibrillary GN (Rituximab)]; Mallinckrodt [IgA nephropathy] and FSGS(Corticotropin injection gel)]; Janssen Pharmaceutical [Monoclonal protein-mediated renal diseases (Daratumumab)]. Consultant/Advisory Boards: Alexion pharmaceutical [complement-mediated diseases]; Visterra pharmaceutical [complement-mediated diseases]. Employment: Mayo Clinic."},{"name":"Maria Isabel Fiel, MD, FAASLD","credentials":["Professor of Pathology\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"Joshua J Field, MD","credentials":["Associate Professor of Medicine\n","Medical College of Wisconsin"],"disclosure":"Grant/Research/Clinical Trial Support: NKT Therapeutics [sickle cell disease (NKTT120)]; Ironwood Pharmaceuticals [sickle cell disease (IW-1701) ]; Prolong Pharmaceuticals [sickle cell disease (Sanguinate)]; Incyte Pharmaceuticals [sickle cell disease (INCB059872)]; Astellas [sickle cell disease (regadenoson)]. Consultant/Advisory Boards: NKT Therapeutics [sickle cell disease (NKTT120)]; Astellas [sickle cell disease (regadenoson)]; Ironwood Pharmaceuticals [sickle cell disease (IW-1701)]."},{"name":"Jay A Fishman, MD","credentials":["Professor of Medicine\n","Harvard Medical School\n","Director, Transplant Infectious Disease and Compromised Host Program\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Steven Flamm, MD","credentials":["Chief, Liver Transplantation Program\n","Professor of Medicine\n","Feinberg School of Medicine\n","Northwestern University"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie, Gilead (HCV). Speaker’s Bureau:\t Abbvie, Gilead, Merck (HCV). Consultant/Advisory Boards: Abbvie, Gilead, Merck (HCV)."},{"name":"Arnold S Freedman, MD","credentials":["Section Editor — Lymphoproliferative Disorders\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Kahr Therapeutics [SAB]. Other Financial Interest: Novartis [DMB (Ofatumumab)]; Bayer [DMB (Bayer 17833)]."},{"name":"Jane E Freedman, MD","credentials":["Professor of Medicine\n","UMass Memorial Heart and Vascular Center"],"disclosure":""},{"name":"W David Freeman, MD","credentials":["Professor of Neurology \n","Mayo Clinic"],"disclosure":""},{"name":"Joy L Fridey, MD","credentials":["Regional Medical Director\n","American Red Cross Blood Services, Southern California"],"disclosure":""},{"name":"Jonathan W Friedberg, MD","credentials":["Professor of Medicine\n","James P Wilmot Cancer Center, University of Rochester"],"disclosure":"Consultant/Advisory Boards: Bayer [DSMB for trials (Investigational agents)]; Astellas [DSMB for trials (Acalabrutinib)]."},{"name":"Lawrence S Friedman, MD","credentials":["Section Editor — General Gastroenterology\n","Professor of Medicine\n","Harvard Medical School\n","Tufts University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Consultant, FDA (Antimicrobial Drugs Advisory Committee); Trustee, Newton-Wellesley Hospital (through June 2017). Employment: Boston Health Care for the Homeless. Other Financial Interest: Elsevier [Gastroenterology (Royalties from textbooks)]; McGraw-Hill [Gastroenterology (Royalties from textbooks)]; Wiley [Gastroenterology (Royalties from textbooks)]; American Society for Gastrointestinal Endoscopy [Gastroenterology and hepatology (Honorarium as newsletter editor)]."},{"name":"Timothy J Friel, MD","credentials":["Associate Clinical Professor of Medicine\n","University of South Florida Morsani College of Medicine"],"disclosure":""},{"name":"Ephraim J Fuchs, MD, MBA","credentials":["Professor of Oncology and Immunology\n","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"],"disclosure":""},{"name":"Barbara C Furie, PhD","credentials":["Professor Emeritus\n","Harvard Medical School"],"disclosure":""},{"name":"Bruce Furie, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"William H Gaasch, MD","credentials":["Section Editor — Valvular Disease\n","Professor of Medicine\n","University of Massachusetts Medical School\n","Tufts University School of Medicine\n","Senior Consultant in Cardiology\n","Lahey Clinic"],"disclosure":""},{"name":"Paul J Gaglio, MD","credentials":["Professor of Medicine (in Surgery)\n","Director: Hepatology Outreach\n","Columbia University College of Physicians and Surgeons Center for Liver Disease and Transplantation \n","\n","NY Presbyterian Hospital-Columbia University Medical Center\n","622 West 168th Street PH 14 Room 202 F\n","NY, NY 10032"],"disclosure":"Consultant/Advisory Boards: Abbvie, Gilead, Salix [Viral hepatitis (Sofosbuvir/Ledipasvir/ Velpatasvir/Voxilaprevir/Glecaprevir Pibrenastvix)]."},{"name":"Najibah A Galadanci, MBBS","credentials":["Bayero University/Aminu Kano Teaching Hospital\n","Kano, Nigeria"],"disclosure":""},{"name":"John M Gansner, MD, PhD","credentials":["Instructor in Medicine\n","Harvard Medical School\n","Associate Physician, Division of Hematology\n","Brigham and Women's Hospital"],"disclosure":""},{"name":"David A Garcia, MD","credentials":["Professor of Medicine, Division of Hematology\n","University of Washington School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Daiichi Sankyo, Janssen/Bayer [anticoagulants (edoxaban, rivaroxaban)]. Consultant/Advisory Boards: BMS, Pfizer, Boehringer Ingelheim [anticoagulants (apixaban, dabigatran, idarucizumab)]."},{"name":"Moira Garraus, MD","credentials":["Paediatric Oncologist\n","Hospital San Joan de Deu"],"disclosure":""},{"name":"Benjamin P Geisler, MD, MPH","credentials":["Instructor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Daniel Gelrud, MD","credentials":["Associate Professor of Clinical Medicine\n","Florida International University"],"disclosure":""},{"name":"Alex George, MD, PhD","credentials":["Assistant Professor of Pediatrics\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Mast therapeutics; Pfizer; Selexys Pharmaceuticals; GBT Pharma; Sancilio Pharmaceuticals [Sickle cell disease (Poloxamer-188, rivipansel, crizanlizumab, GBT440, SC411)]."},{"name":"James N George, MD","credentials":["Professor of Medicine\n","University of Oklahoma Health Sciences Center"],"disclosure":"Grant/Research/Clinical Trial Support: Ablynx [TTP (caplacizumab)]."},{"name":"Tracy I George, MD","credentials":["Professor\n","Department of Pathology\n","University of Utah"],"disclosure":"Consultant/Advisory Boards: Roche [hematology (Cobas m 511 (instrument) - not available in US yet)]. Employment: ARUP Laboratories."},{"name":"Bertil Glader, MD, PhD","credentials":["Professor of Pediatrics\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Lucy A Godley, MD, PhD","credentials":["Professor of Medicine\n","The University of Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Onconova, Inc [epigenetic profiling of rigosertib response (rigosertib)]."},{"name":"Dennis Goldfinger, MD","credentials":["Consulting Specialist, MD\n","Olive View Medical Center"],"disclosure":""},{"name":"David Goltzman, MD","credentials":["Professor of Medicine\n","McGill University\n","Senior Physician, Division of Endocrinology and Department of Medicine\n","McGill University Health Centre"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen; Eli Lilly; Merck [Osteoporosis]. Consultant/Advisory Boards: Amgen [Osteoporosis (Denosumab)]."},{"name":"Peter D Gorevic, MD","credentials":["Professor of Medicine, Rheumatology\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"Kaoru Goshima, MD","credentials":["Associate Professor, Surgery\n","University of Arizona Health Sciences Center"],"disclosure":""},{"name":"Mrinal M Gounder, MD","credentials":["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Sarcoma (Sorafenib)]. Consultant/Advisory Boards: Epizyme; Karyopharm; Daiichi-Sankyo; Amgen [Sarcoma (None)]."},{"name":"Thomas J Graetz, MD","credentials":["Associate Professor of Anesthesiology and Surgery (Cardiothoracic)\n","Washington University in St. Louis School of Medicine"],"disclosure":""},{"name":"Frank G Gress, MD","credentials":["Professor of Medicine \n","Columbia University College of Physicians and Surgeons"],"disclosure":""},{"name":"Thomas G Gross, MD, PhD","credentials":["Deputy Director for Science\n","Center for Global Health, NCI, NIH, DHHS"],"disclosure":""},{"name":"Paul A Gurbel, MD","credentials":["Director, Cardiovascular Research, Inova Heart and Vascular Institute \n","Professor\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Haemonetics/Coramed [Instrumentation (Thromboelastography)]; Amgen [Cardiology (evolocumab)]; DCRI [Interventional cardiology]; NIH [Interventional cardiology (PAR-1 blocker)]; Merck [Cardiology (PAR-1 inhibitor)]. Ionis [Cardiology]. Consultant/Advisory Boards: Boehringer; Merck; Janssen; Bayer. Patent Holder: Platelet function testing. Equity Ownership/Stock Options: Merck."},{"name":"Sandeep Gurbuxani, MBBS, PhD","credentials":["Associate Professor, Section of Hematopathology, Department of Pathology\n","University of Chicago"],"disclosure":""},{"name":"Michael Gurish, PhD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Arete Discoveries [Mast cell biology and multiple sclerosis (Proprietary research)]. Other Financial Interest: Expert witness for Conway, Homer, and Chin-Caplan [Autoimmunity (Provide expert opinions)]."},{"name":"Katherine A Hajjar, MD","credentials":["Professor of Pediatrics, Brine Family Professor of Cell and Developmental Biology\n","Weill Cornell Medicine"],"disclosure":""},{"name":"Paul Harrison, PhD","credentials":["Senior Lecturer, School of Immunity and Infection\n","University of Birmingham Medical School"],"disclosure":""},{"name":"Frances J Hayes, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Michele Heath, LP, CCP","credentials":["Perfusionist\n","Durham VA Medical Center"],"disclosure":""},{"name":"Matthew Heeney, MD","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Sancilio Pharmaceuticals Company [Sickle cell treatment (SC411)]; Pfizer [Sickle cell treatment (Rivipansel)]; Astra Zeneca [Sickle cell treatment (Ticagrelor)]. Consultant/Advisory Boards: Sancilio Pharmaceuticals Company [Sickle cell treatment (SC411)]; AstraZeneca [Sickle cell treatment (Ticagrelor)]; Novartis [Sickle cell treatment (Crizanlizumab)]."},{"name":"Charles H Hennekens, MD, DrPH","credentials":["First Sir Richard Doll Professor & Senior Academic Advisor to the Dean, Charles E. Schmidt College of Medicine, Florida Atlantic University\n","Clinical Professor, Nova Southeastern University\n","Voluntary Professor, University of Miami Miller School of Medicine, Meharry Medical College, and Baylor Colle"],"disclosure":"Consultant/Advisory Boards: United States Food and Drug Administration [Cardiovascular disease]; Pfizer [Varenicline] and its legal counsel [Atorvastatin]. Patent Holder: Co-inventor on patents concerning inflammatory markers and cardiovascular disease held by Brigham and Women's Hospital [C-reactive protein]. Equity Ownership/Stock Options: SunTrustBank; The West-Bacon Group has discretionary authority and excludes any common or preferred stock in any pharmaceutical or medical device company."},{"name":"William L Henrich, MD, MACP","credentials":["Professor of Medicine\n","President of the Health Science Center\n","University of Texas Health Science Center School of Medicine"],"disclosure":""},{"name":"John R Hess, MD, MPH","credentials":["Professor\n","University of Washington School of Medicine"],"disclosure":"Patent Holder: Haemonetics [Blood cell storage (additive solution -7)]; University of Maryland; Remedium Corporation [Hemorrhage control bandage (hydrophobically modified chitosan)]; [Hemorrhage control (clotting factor 7a and fibrinogen)]."},{"name":"Patricia L Hibberd, MD, PhD","credentials":["Chair, Department of Global Health\n","Boston University School of Public Health"],"disclosure":""},{"name":"Johann Hitzler, MD, FRCP(C), FAAP","credentials":["Professor, Department of Pediatrics\n","University of Toronto"],"disclosure":""},{"name":"Ephraim Hochberg, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Fred H Hochberg, MD","credentials":["Professor, Department of Neurology\n","University of California at San Diego Moores Cancer Center"],"disclosure":""},{"name":"Maureane Hoffman, MD, PhD","credentials":["Professor of Pathology\n","Duke University"],"disclosure":""},{"name":"Leona A Holmberg, MD, PhD","credentials":["Associate Professor of Medicine, University of Washington\n","Member, Fred Hutchinson Cancer Research Center"],"disclosure":"Grant/Research/Clinical Trial Support: Seattle Genetics, Merck, Millennium, Sanofi [maintenance therapy after ASCT, mobilization therapy for ASCT]. Consultant/Advisory Boards: Seattle Genetics [maintenance post-ASCT for HD], Jazz [VOD/SOS therapy]."},{"name":"W Keith Hoots, MD","credentials":["Director, Division of Blood Diseases and Resources\n","National Heart, Lung and Blood Institute\n","National Institutes of Health, Bethesda, Maryland"],"disclosure":""},{"name":"Carolyn Hoppe, MD","credentials":["Associate Hematologist/Oncologist, UCSF Benioff Children's Hospital Oakland\n","Associate Scientist, Children's Hospital Oakland Research Institute\n","Director, Hemoglobinopathy Reference Laboratory"],"disclosure":"Consultant/Advisory Boards: Bio-Rad Laboratories [Hematology/hemoglobinopathy testing (HPLC)]."},{"name":"Richard T Hoppe, MD","credentials":["Professor of Radiation Oncology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Terzah M Horton, MD, PhD","credentials":["Assistant Professor, Hematology/Oncology\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda Pharmaceuticals/Millennium [Proteasome inhibitors (Bortezomib); Seattle Genetics [Anti-CD30 antibodies (Brentuximab)]."},{"name":"Steven Horwitz, MD","credentials":["Associate Attending\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene Corporation [mycosis fungoides (romidepsin)]; Millennium Pharmaceuticals/Takeda [Hodgkin lymphoma (brentuximab vedotin)]; Kyowa-Hakka-Kirin [mycosis fungoides (mogamulizumab)]; Seattle Genetics [Hodgkin lymphoma (brentuximab vedotin)]; Spectrum Pharmaceuticals [mycosis fungoides (pralatrexate)]; Forty-Seven; Infinity/Verastem; ADCT Therapeutics; Aileron Therapeutics. Consultant/Advisory Boards: Celgene Corporation; Millennium Pharmaceuticals/Takeda; Kyowa-Hakka-Kirin; Seattle Genetics; Forty-Seven; Infinity/Verastem; HUYA; BMA; Mundipharma."},{"name":"Warner K Huh, MD","credentials":["Margaret Cameron Spain Chair in Obstetrics/Gynecology\n","Professor, Division of Gynecologic Oncology\n","Senior Scientist, UAB Comprehensive Cancer Center"],"disclosure":"Consultant/Advisory Boards: Merck [Cervical cytology (HPV vaccines)]; Intuitive Surgical (Robotic Surgery); LICOR (fluorescence imaging); InCellDx (cervical cancer screening)."},{"name":"Russell D Hull, MBBS, MSc","credentials":["Professor of Medicine\n","University of Calgary, Canada"],"disclosure":"Grant/Research/Clinical Trial Support: LEO Pharma [VTE (Tinzaparin)]; Sanofi [VTE (Enoxaparin)]; Portola [VTE (Betrixaban)]; Bayer [VTE (Rivaroxaban)]."},{"name":"Michael Ieong, MD","credentials":["Assistant Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Lesley A Inker, MD, MS","credentials":["Associate Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Nicolas Intagliata, MD","credentials":["Assistant Professor of Medicine\n","University of Virginia"],"disclosure":""},{"name":"Eric Jacobsen, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [Histiocytoses (Lenalidomide)]. Consultant/Advisory Boards: Seattle Genetics [T cell lymphoma (Brentuximab)]; Spectrum [T cell lymphoma (Pralatrexate, romidepsin)]; Merck (Temsirolimus); Pharmacyclics (Ibrutinib)."},{"name":"Anuja Java, MD","credentials":["Instructor in Medicine\n","Washington University School of Medicine"],"disclosure":""},{"name":"Richard B Johnston, Jr, MD","credentials":["Emeritus Professor of Pediatrics\n","University of Colorado School of Medicine\n","National Jewish Health"],"disclosure":""},{"name":"Kala Kamdar, MD, MS Epi","credentials":["Associate Professor, Department of Pediatrics, Section of Hematology/Oncology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Robert J Kaner, MD","credentials":["Associate Professor of Clinical Medicine\n","Weill Medical College of Cornell University"],"disclosure":""},{"name":"David S Kang, MD, PhD","credentials":["Director of Biomedical Genetics\n","Rush Medical College"],"disclosure":""},{"name":"Andre A Kaplan, MD","credentials":["Professor of Medicine\n","University of Connecticut Health Center"],"disclosure":"Grant/Research/Clinical Trial Support: Nipro Corporation [Dialysis (Dialysis filters)]. Speaker's Bureau: Terumo [Plasmapheresis (Plasmapheresis machines)]. Consultant/Advisory Boards: Vital Therapeutics [Extracorporeal liver assist device (ELAD)]."},{"name":"Lawrence D Kaplan, MD","credentials":["Clinical Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Steven M Kawut, MD","credentials":["Associate Professor of Medicine and Epidemiology, Director, Pulmonary Vascular Disease Program\n","Perelman School of Medicine, University of Pennsylvania"],"disclosure":""},{"name":"Clive Kearon, MB, MRCP(I), FRCP(C), PhD","credentials":["Jack Hirsh Professorship in Thromboembolism\n","Department of Medicine, McMaster University"],"disclosure":"Grant/Research/Clinical Trial Support (Spouse): Stago [VTE diagnosis (D-dimer assay)]."},{"name":"Melanie S Kennedy, MD","credentials":["Clinical Associate Professor Emeritus\n","Department of Pathology, The Ohio State University"],"disclosure":""},{"name":"Shakila Khan, MD","credentials":["Associate Professor of Pediatrics\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Ellen J Kim, MD","credentials":["Associate Professor of Dermatology\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Kyowa Hakko Kirin [CTCL clinical trial investigator (anti-CCR4 [KW0761, mogamulizumab])]; Solgenix [CTCL clinical trial investigator (hypericin photodynamic topical agent)]; Actelion [CTCL clinical trial investigator (nitrogen mustard gel)]. Consultant/Advisory Boards: Actelion [CTCL (nitrogen mustard gel)]."},{"name":"Youn H Kim, MD","credentials":["Professor of Dermatology\n","Stanford University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Esai [CTCL (E7777/denileukin diftitox)], Kyowa Hakko Kirin [CTCL (mogamulizumab)], Merck [CTCL (Pembromulizumab)], Millennium/Takeda [CTCL (brentuximab vedotin)], Seattle Genetics [CTCL (brentuximab vedotin)], Soligenix [CTCL (TOPICAL SGX301)], Tetralogic [CTCL (SHAPE)], Neumedicine [CTCL (Interleukin-12)], Innate [CTCL (IPH4102)], Infinity Pharmaceuticals. Consultant/Advisory Boards: Actelion [CTCL], Celgene [CTCL (Romidepsin)], Eisai [CTCL (E7777/denileukin diftitox)], Galderma [CTCL], Kyowa Hakko Kirin [CTCL (Mogamulizumab)], Millennium/Takeda Pharma [CTCL (Brentuximab Vedotin)], Seattle Genetics [CTCL (Brentuximab Vedotin)], Forty Seven Inc [CTCL], Horizon Pharma [CTCL (Actimmune)], Portola Pharma [CTCL (Cerdulatinib)], miRagen [CTCL (AntimiR-155 MRG-106)], Medivir."},{"name":"Christina L Klein, MD","credentials":["Transplant Nephrologist\n","Piedmont Transplant Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [CMV (CMV vaccine)]; Chimerix [CMV (Brincidofovir)]. Speaker's Bureau: Alexion [Atypical HUS (Eculizumab)]. Consultant/Advisory Boards: Alexion [Atypical HUS (Eculizumab)]."},{"name":"Steven Kleinman, MD","credentials":["Section Editor — Transfusion Medicine\n","Clinical Professor of Pathology\n","University of British Columbia, Vancouver"],"disclosure":"Consultant/Advisory Boards: Cerus Corp [Pathogen reduction of blood components (Intercept Blood system)]. Equity Ownership/Stock Options: Cerus Corp."},{"name":"Heidi D Klepin, MD, MS","credentials":["Associate Professor of Internal Medicine, Hematology and Oncology\n","Comprehensive Cancer Center of Wake Forest University"],"disclosure":""},{"name":"Elizabeth S Klings, MD","credentials":["Associate Professor of Medicine\n","Boston University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Actelion Pharmaceuticals [Pulmonary hypertension, sickle cell disease (Macitentan, bosentan, selexipag)]; Bayer Pharmaceuticals [sickle cell disease vasculopathy (riociguat)]; Reata pharmaceuticals [Pulmonary hypertension (Bardoxolone methyl)], Arena pharmaceuticals [Pulmonary hypertension (APD811)], Eiger pharmaceuticals [Pulmonary hypertension (Ubenimex)]. Consultant/Advisory Boards: Pfizer (Vasoocclusive crisis, sickle cell disease [Rivipanzel])."},{"name":"Amy D Klion, MD","credentials":["Baltimore, MD"],"disclosure":""},{"name":"E Anders Kolb, MD","credentials":["Director, Nemours Center for Cancer and Blood Disorders\n","Nemours/Alfred I duPont Hospital for Children"],"disclosure":""},{"name":"Jonathan E Kolitz, MD","credentials":["Professor of Medicine\n","Hofstra Northwell School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Celator [AML (CPX-351)]; Boehringer-Ingelheim [AML (volasertib, BI836858)]; Millennium [AML, MDS (pevonedistat)]; Cantex [AML (CX-01)]; Erytech Pharma [ALL (ERYASP)]. Consultant/Advisory Boards: Pharmacyclics, Seattle Genetics, Novartis, Gilead."},{"name":"Daryl J Kor, MD","credentials":["Professor of Anesthesiology\n","Mayo Clinic"],"disclosure":"Consultant/Advisory Boards: CSL Behring [Advisory Board for 2017-2018 (Prothrombin Complex Concentrate)]."},{"name":"Abhijit V Kshirsagar, MD, MPH","credentials":["Associate Professor of Medicine\n","University of North Carolina at Chapel Hill"],"disclosure":""},{"name":"Irving Kushner, MD","credentials":["Professor Emeritus\n","Case Western Reserve University"],"disclosure":""},{"name":"David J Kuter, MD, DPhil","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Protalix, BMS [TPO (romiplostim)]. Consultant/Advisory Boards: Amgen, Novartis, 3SBIO, Syntimmune, Pfizer, Rigel, Argenx [Treatment of ITP (romiplostim, IVIG, monoclonal antibodies, rhTPO)]."},{"name":"Robert A Kyle, MD","credentials":["Section Editor — Plasma Cell Disorders\n","Professor of Medicine\n","Mayo Medical School"],"disclosure":"Consultant/Advisory Boards: Celgene Disease Monitoring Committee [Dysproteinemias (lenalidomide, pomalidomide)]; Bristol-Myers Squibb Independent Monitoring Committee [Dysproteinemias (elotuzumab)]; Onyx Pharma (Amgen) Data Monitoring Committee [Dysproteinemias (carfilzomib)]; Pharmacyclics Data Safety Monitoring Board [Dysproteinemias (ibrutinib)]. Other Financial Interest: Pfizer [Lecture on therapy of multiple myeloma, made comments concerning a new Pfizer product and received an honorarium]."},{"name":"Ann S LaCasce, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board: BMS (DMB); Seattle Genetics (education materials)."},{"name":"Thierry Lamy, MD, PhD","credentials":["Professor in Hematology\n","University of Rennes, France"],"disclosure":""},{"name":"Richard A Larson, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Leukemia\n","Professor of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [leukemia (gilteritinib)]; Erytech [leukemia (eryaspase)]; Novartis [leukemia (nilotinib, ascininib)]; Daiichi Sankyo [leukemia (quizartinib)]; Celgene [leukemia (enasidenib)]. Consultant/Advisory Boards: Novartis [leukemia (imatinib, nilotinib)]; Ariad Data Safety Monitoring Board [leukemia (ponatinib)]; CVS/Caremark [leukemia (drug prior authorization program)]; Celgene Data Safety Monitoring Board [leukemia (azacitidine, durvalumab)]; Amgen [leukemia (blinatumomab)]; Astellas [leukemia (gilteritinib)]; Jazz [leukemia (CPX-351)]."},{"name":"Michelle M Le Beau, PhD","credentials":["Professor of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":""},{"name":"Eudocia Quant Lee, MD, MPH","credentials":["Assistant Professor of Neurology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Genentech/Roche [Radiographic response criteria for brain Metastases]; Lilly [Brain metastases]."},{"name":"Michael D Leise, MD","credentials":["Assistant Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Hepatitis C (Grazoprevir, elbasvir)]; Abbvie [Hepatitis C (Glecaprevir/Pibrentasvir)]."},{"name":"Edgar V Lerma, MD, FACP, FASN, FAHA","credentials":["SGIM Peer Reviewer\n","Clinical Professor of Medicine\n","University of Illinois at Chicago College of Medicine"],"disclosure":""},{"name":"Lawrence LK Leung, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Disorders of Hemostasis and Coagulation\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Nelson Leung, MD","credentials":["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Omeros Corporation [thrombotic microangiopathy]. Consultant/Advisory Boards: Prothena [amyloidosis]; Thrasos Therapeutics [myeloma kidney (cast nephropathy)]."},{"name":"Rodger A Liddle, MD","credentials":["Professor of Medicine\n","Duke University Medical School"],"disclosure":""},{"name":"A Michael Lincoff, MD","credentials":["Director, Center for Clinical Research\n","Professor of Medicine\n","Cleveland Clinic Lerner College of Medicine of Case Western Reserve University"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Dyslipidemia (Evolocumab)]; AstraZeneca [Dyslipidemia (Epanova) and coronary artery disease (Ticagrelor)]; CSL Behring [Dyslipidemia (CSL-112)]; Edwards [Valvular heart disease (Edwards Sapien valve)]; Eli Lilly [Dyslpidemia (Evacetrapib)]; Esperion [Dyslipidemia (Bempedoic acid)]; Medicines Company [Dyslipidemia (MDCO-216)]; Pfizer [COX-2 CV safety (Celecoxib)]; Roche [Diabetes (Aleglitazar)]; AbbVie [Testosterone CV safety (AndroGel)]. Consultant/Advisory Boards: Amgen [Dyslipidemia (Evolocumab)]; Sanofi [Diabetes (iGlarLixi)]; Novo Nordisk [Diabetes and obesity (Semaglutide)]."},{"name":"Gregory YH Lip, MD, FRCPE, FESC, FACC","credentials":["Professor of Cardiovascular Medicine\n","The University of Birmingham, UK"],"disclosure":"Speaker's Bureau: Bayer [Atrial fibrillation and thrombosis (rivaroxaban)]; BMS/Pfizer [Atrial fibrillation and thrombosis (apixaban)]; Boehringer Ingelheim [Atrial fibrillation and thrombosis (dabigatran)]; Daiichi-Sankyo [Atrial fibrillation and thrombosis (edoxaban)]; Medtronic [Atrial fibrillation and thrombosis]; Sanofi Aventis [Atrial fibrillation and thrombosis]. Consultant/Advisory Boards: Bayer/Janssen [Atrial fibrillation and thrombosis (rivaroxaban)]; BMS/Pfizer [Atrial fibrillation and thrombosis (apixaban)]; Boehringer Ingelheim [Atrial fibrillation and thrombosis (dabigatran)]; Daiichi-Sankyo [Atrial fibrillation and thrombosis (edoxaban)]; Medtronic [Atrial fibrillation and thrombosis]."},{"name":"M Kathryn Liszewski, PhD","credentials":["Assistant Professor of Medicine\n","Washington University School of Medicine"],"disclosure":""},{"name":"Michael D Lockshin, MD, MACR","credentials":["Director\n","Barbara Volcker Center for Women and Rheumatic Disease\n","Professor of Medicine and Obstetrics-Gynecology\n","Joan and Sanford Weill College of Medicine of Cornell University"],"disclosure":""},{"name":"Charles J Lockwood, MD, MHCM","credentials":["Section Editor — Obstetrics\n","Senior Vice President, USF Health \n","Dean, Morsani College of Medicine \n","Professor, Obstetrics and Gynecology \n","University of South Florida"],"disclosure":""},{"name":"Jay S Loeffler, MD","credentials":["Section Editor — Neurooncology\n","Professor of Radiation Oncology\n","Harvard Medical School"],"disclosure":""},{"name":"Charles L Loprinzi, MD","credentials":["Regis Professor of Breast Cancer Research\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Prevention and treatment of chemotherapy-induced peripheral neuropathy (pregabalin)]; Pfizer [Treating blood clots (Apixaban)]; Janssen [Preventing blood clots (Rivaroxaban)]. Consultant/Advisory Boards: Mitsubishi Tanabe Pharma [menopausal hot flashes]; PledPharma; Metys; Lpath; Mundipharma [Prevention and treatment of chemotherapy-induced peripheral neuropathy]."},{"name":"Thomas P Loughran, Jr, MD","credentials":["Director, University of Virginia Cancer Center\n","University of Virginia"],"disclosure":""},{"name":"Qun Lu, MD","credentials":["Senior Associate Consultant\n","Mayo Clinic"],"disclosure":""},{"name":"Bertram H Lubin, MD","credentials":["Adjunct Professor of Pediatrics, University of California San Francisco\n","CEO and President, Children’s Hospital and Research Center, Oakland"],"disclosure":""},{"name":"Leo Luznik, MD","credentials":["Associate Professor of Oncology\n","The Johns Hopkins University"],"disclosure":""},{"name":"Donald H Mahoney, Jr, MD","credentials":["Section Editor — Pediatric Hematology\n","Professor of Pediatrics\n","Baylor College of Medicine"],"disclosure":""},{"name":"Atul Malhotra, MD","credentials":["Kenneth M Moser Professor, Department of Medicine\n","University of California, San Diego"],"disclosure":""},{"name":"Andrew Malone, MB, BCh, MRCPI","credentials":["Assistant Professor of Medicine, Division of Nephrology\n","Department of Medicine, Washington University School of Medicine"],"disclosure":""},{"name":"John P Manis, MD","credentials":["Assistant Professor of Pathology\n","Harvard Medical School\n","Joint Program in Transfusion Medicine, Dep"],"disclosure":""},{"name":"Pier Mannuccio Mannucci, MD","credentials":["Section Editor — Disorders of Hemostasis and Coagulation\n","Professor of Internal Medicine, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center\n","University of Milan, Italy"],"disclosure":"Speaker's Bureau: Shire, Bayer, Grifols, Kedrion Biopharma, Novo Nordisk, LFB [hemophilia, coagulation disorders]. Consultant/Advisory Boards: Bayer, Kedrion Biopharma [hemophilia, coagulation disorders]."},{"name":"Lawrence B Marks, MD","credentials":["Department of Radiation Oncology\n","UNC Hospitals and University of North Carolina at Chapel Hill"],"disclosure":"Grant/Research/Clinical Trial Support: Vision RT [Radiation therapy (Breath-holding system to reduce cardiac effects of radiation)]."},{"name":"Joel B Mason, MD","credentials":["Professor of Medicine and Nutrition\n","Tufts University Schools of Medicine and Nutrition\n","USDA Human Nutrition Research Center at Tufts University"],"disclosure":"Grant/Research/Clinical Trial Support: Quintiles Inc[Short bowel syndrome(Performance of clinical trials)]. Consultant/Advisory Board: Shire Pharmaceuticals [Short bowel syndrome/malabsorption (Teduglutide)]."},{"name":"Masao Matsuoka, MD, PhD","credentials":["Professor\n","Department of Hematology, Kumamoto University Medical School\n","Institute for Virus Research, Kyoto University"],"disclosure":""},{"name":"Kenneth L McClain, MD, PhD","credentials":["Professor of Pediatrics\n","Texas Children's Cancer Center/Hematology Service\n","Baylor College of Medicine"],"disclosure":""},{"name":"Meredith C McCormack, MD, MHS","credentials":["Assistant Professor of Medicine\n","Medical Director, Pulmonary Function Laboratory Pulmonary and Critical Care Medicine Johns Hopkins University"],"disclosure":""},{"name":"Douglas McDonald, MD, PhD","credentials":["Assistant Professor of Pediatrics\n","Boston Children's Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"Iain B McInnes, FRCP, PhD","credentials":["Professor of Medicine\n","University of Glasgow"],"disclosure":"Grant/Research Support: Pfizer [Inflammatory arthritis (Etanercept, tofacitinib)]; UCB [Inflammatory arthritis (Certolizumab)]; Janssen [Inflammatory arthritis (Ustekinumab)]; BMS [Inflammatory arthritis (Abatacept)]; Celgene. Consultant/Advisory Boards: Pfizer [Inflammatory arthritis (Etanercept, tofacitinib)]; UCB [Inflammatory arthritis (Certolizumab)]; Janssen [Inflammatory arthritis (Ustekinumab)]; Novartis [Inflammatory arthritis (Secukinumab)]; AbbVie [Inflammatory arthritis (Adalimumab)]; BMS [Inflammatory arthritis (Abatacept)]; MSD [Inflammatory arthritis (Golimumab)]; Lilly [Inflammatory arthritis (Baricitinib)]."},{"name":"Jennifer J McIntosh, DO, MS","credentials":["Assistant Professor of Maternal Fetal Medicine\n","Medical College of Wisconsin"],"disclosure":""},{"name":"William J McKenna, MD","credentials":["Section Editor — Myopericardial Disease\n","Professor of Cardiology\n","University College, London"],"disclosure":""},{"name":"C Crawford Mechem, MD, FACEP","credentials":["Professor of Emergency Medicine\n","Perelman School of Medicine, University of Pennsylvania"],"disclosure":""},{"name":"William C Mentzer, MD","credentials":["Section Editor — Red Cell Disorders\n","Professor of Pediatrics\n","University of California, San Francisco"],"disclosure":"Equity Ownership/Stock Options: Johnson & Johnson [Anemia (Erythropoietin)]."},{"name":"Peter A Merkel, MD, MPH","credentials":["Section Editor — Vasculitis\n","Chief, Division of Rheumatology\n","University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Actelion [scleroderma]; Bristol-Myers Squibb [vasculitis (abatacept)]; Celgene [vasculitis (apremilast)]; ChemoCentryx [vasculitis (avocopan)]; Genentech/Roche [vasculitis (rituximab, tocilizumab)]; GlaxoSmithKline [vasculitis (belimumab, mepolimumab, sirukumab)]; Kypha [vasculitis]; MedImmune [vasculitis]; TerumoBCT [vasculitis]. Consultant/Advisory Boards: Abbvie [vasculitis]; Actelion [scleroderma]; Bristol-Myers Squibb [vasculitis]; Beoringher Ingelheim [scleroderma]; ChemoCentryx [vasculitis (avocopan)]; Genentech/Roche[vasculitis (rituximab, tocilizumab)]; GlaxoSmithKline [vasculitis (belimumab, mepolimumab)]; InflaRx [vasculitis]; PrincipiaBio [vasculitis]; Prothena [vasculitis]; Seattle Genetics [vasculitis]."},{"name":"Alain Meyrier, MD","credentials":["Professor of Medicine (Emeritus)\n","Université Paris-Descartes, Paris, France"],"disclosure":""},{"name":"Vladan Milovic, MD, PhD","credentials":["Associate Professor of Medicine\n","Head, Department of Gastroenterology & Oncology Reha-Zentrum Bad Reichenhall / \n","Bayerisch Gmain Klinik Hochstaufen Bayerisch Gmain \n","Bayern, Germany"],"disclosure":""},{"name":"Sahil Mittal, MD, MS","credentials":["Assistant Professor\n","Baylor College of Medicine"],"disclosure":""},{"name":"Kenneth J Moise Jr, MD","credentials":["Professor of Obstetrics, Gynecology and Reproductive Sciences\n","Professor of Pediatric Surgery\n","University of Texas School of Medicine at Houston"],"disclosure":"Grant/Research/Clinical Trial Support: Momenta Pharmaceutical, Inc [Transplacental characteristics of maternal antibody in HDFN]. Consultant/Advisory Boards: Momenta Pharmaceutical, Inc [Rhesus disease (Fc receptor blocking monoclonal antibody (not yet in clinical trials))]; LFB Biotechnologies [Development of synthetic Rhesus immune globulin (Roledumab, synthetic Rhesus immune globulin (clinical trial planning))]."},{"name":"Craig Moskowitz, MD","credentials":["Attending Physician, Lymphoma and Adult BMT Services\n","Member, Memorial Sloan Kettering Cancer Center \n","Professor of Medicine, Weill Medical College of Cornell University"],"disclosure":""},{"name":"David B Mount, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Ardea [Urate transport (Lesinurad)]. Consultant/Advisory Boards: ZS Pharma [Potassium (ZS9)]; Relypsa [Potassium (Patiromer)]."},{"name":"Nikhil C Munshi, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Janssen [Castleman disease (siltuximab)]."},{"name":"Anupama Narla, MD","credentials":["Assistant Professor of Pediatrics (Hematology/Oncology)\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Mohandas Narla, DSc","credentials":["Vice President for Research\n","New York Blood Center"],"disclosure":""},{"name":"Robert S Negrin, MD","credentials":["Section Editor — Bone Marrow Transplantation\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Immuno-oncology]; Jazz Pharmaceuticals [Veno-occlusive disease (Defibrotide)]; Cell Source [Cellular therapy]; Magenta Pharmaceuticals [Transplantation]. Equity Ownership/Stock Options: Concentrx [Cellular immunotherapy]; Magenta Pharmaceuticals [Transplantation]; Cell Source [Cellular therapy]. Other Financial Interest: American Society of Hematology [Editor in Chief of \"Blood Advances\"]."},{"name":"Carla Nester, MS, MD","credentials":["Assistant Professor\n","University of Iowa"],"disclosure":"Grant/Research/Clinical Trial Support: Retrophin [PI – Duet Study - Endothelin Receptor Blocker in Pediatric Patients with FSGS (RE-021)]; Avacopan [PI – A randomized, double-blind, placebo-controlled phase 2 study to evaluate the safety and efficacy of avacopan (CCX168) in patients with CS glomerulopathy]."},{"name":"Andrea K Ng, MD, MPH","credentials":["Professor, Radiation Oncology, Harvard Medical School\n","Brigham and Women's Hospital\n","Dana-Farber Cancer Institute"],"disclosure":""},{"name":"Lynnette K Nieman, MD","credentials":["Section Editor — Adrenal Disease\n","Senior Investigator\n","Bethesda, MD"],"disclosure":"Grant/Research/Clinical Trial Support: HRA Pharma [Cushing's syndrome (Metapyrone)]."},{"name":"Gregory Nuttall, MD","credentials":["Professor of Anesthesiology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Mark D Okusa, MD","credentials":["Professor of Medicine\n","University of Virginia Health System"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [AKI]; John Bower Foundation [AKI]; Pfizer [Acute kidney injury (Recombinant alkaline phosphatase)]. Consultant/Advisory Boards: AM Pharma [AKI]. Patent Holder: B2 pharmaceutical compositions having A2A adenosine receptor agonist activity; Methods and compositions for treating inflammatory response. Equity Ownership/Stock Options: Adenosine Therapeutics [AKI]."},{"name":"Elise A Olsen, MD","credentials":["Professor of Dermatology and Oncology\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Bioniz [CTCL, consultant]; Galderma [CTCL, investigator clinical trial]; Elorac [CTCL, investigator clinical trial]."},{"name":"Timothy S Olson, MD, PhD","credentials":["Assistant Professor of Pediatrics\n","Comprehensive Bone Marrow Failure Center and Blood and Marrow Transplant Section\n","Divisions of Pediatric Oncology and Hematology\n","The Children's Hospital of Philadelphia and University of Pennsylvania"],"disclosure":""},{"name":"Thomas L Ortel, MD, PhD","credentials":["Professor of Medicine & Pathology\n","Hemostasis & Thrombosis Center, Duke University"],"disclosure":"Grant/Research/Clinical Trial Support: Instrumentation Laboratory [coagulation laboratory testing (coagulation laboratory test instruments and reagents)]; Stago [coagulation laboratory testing (coagulation laboratory test instruments and reagents)]; Siemens [coagulation laboratory testing (coagulation laboratory test instruments and reagents)]."},{"name":"Eric Padron, MD","credentials":["Assistant Member, Malignant Hematology\n","H. Lee Moffitt Cancer Center and Research Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte, CTI, KaloBios [CMML (ruxolitinib, pacritinib)]. Consultant/Advisory Boards: CTI, Incyte [myelofibrosis (pacritinib)]."},{"name":"Menaka Pai, MD, FRCPC","credentials":["Associate Professor, Hematology and Thromboembolism\n","McMaster University"],"disclosure":"Speaker's Bureau: Bayer [VTE (rivaroxaban)]. Consultant/Advisory Boards: Bayer [VTE (rivaroxaban)]; BMS-Pfizer [VTE (apixaban)]."},{"name":"Biff F Palmer, MD","credentials":["Professor of Internal Medicine\n","University of Texas Southwestern Medical Center"],"disclosure":""},{"name":"Chirag Parikh, MD, PhD","credentials":["Professor of Medicine\n","Yale University School of Medicine"],"disclosure":""},{"name":"Stanford L Peng, MD, PhD","credentials":["Clinical Assistant Professor\n","University of Washington"],"disclosure":""},{"name":"Elizabeth Peralta, MD","credentials":["Surgical Oncologist\n","Sutter Pacific Medical Foundation"],"disclosure":""},{"name":"Ronald D Perrone, MD","credentials":["Section Editor — Cystic Disease\n","Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [Polycystic kidney disease (Tolvaptan)]; Kadmon [Polycystic kidney disease (Tesevatinib)]; Department of Defense [Polycystic kidney disease (Metformin)]. Consultant/Advisory Boards: Otsuka [Polycystic kidney disease (Tolvaptan)]; Novartis [Polycystic kidney disease]; Misubishi Tanabe [Polycystic kidney disease]; Sanofi-Genzyme [Polycystic kidney disease]."},{"name":"Jacquelyn M Powers, MD, MS","credentials":["Assistant Professor of Pediatrics\n","Baylor College of Medicine"],"disclosure":""},{"name":"Olga Pozdnyakova, MD","credentials":["Assistant Professor of Pathology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Promedior [myeloproliferative neoplasms]."},{"name":"Josef T Prchal, MD","credentials":["Professor of Medicine\n","University of Utah"],"disclosure":""},{"name":"Elizabeth A Price, MD","credentials":["Assistant Professor\n","Stanford University Medical Center"],"disclosure":""},{"name":"Wajeh Y Qunibi, MD","credentials":["Professor of Medicine\n","University of Texas Health Sciences Center"],"disclosure":""},{"name":"Alejandro A Rabinstein, MD","credentials":["Associate Professor of Neurology \n","Mayo Clinic"],"disclosure":""},{"name":"Benjamin A Raby, MD, MPH","credentials":["Section Editor — Genetics\n","Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Equity Ownership/Stock Options: CureSpark, Inc [General science]. Employment (spouse): Parexel [Hematology (CRO)] - No relevant conflict on topic."},{"name":"Jai Radhakrishnan, MD, MS","credentials":["Professor of Medicine\n","Columbia University Medical Center"],"disclosure":""},{"name":"Kanti R Rai, MD","credentials":["Professor of Medicine and Molecular Medicine\n","Zucker School of Medicine at Hofstra/Northwell"],"disclosure":"Advisory Boards: Pharmacyclics [CLL (ibrutinib)], Gilead [CLL (idelalisib)], Roche/Genentech [CLL (obinutuzumab, rituximab)], Cellectis [CLL (not named, generic: allogeneic CAR-T cells)]."},{"name":"S Vincent Rajkumar, MD","credentials":["Edward W. and Betty Knight Scripps Professor of Medicine\n","Mayo Clinic"],"disclosure":""},{"name":"Gary E Raskob, MSc, PhD","credentials":["Professor, Biostatistics, Epidemiology and Medicine\n","University of Oklahoma Health Sciences Center"],"disclosure":"Consultant/Advisory Boards: Bayer Healthcare [Thromboembolic disease (Rivaroxaban)]; BMS [Thromboembolic disease (Apixaban)]; Boehringer-Ingelheim [Thromboembolic disease (Dabigatran)]; Daiichi Sankyo [Thromboembolic disease (Edoxaban)]; Eli Lilly [Cancer/thrombosis (Necitumumab)]; Janssen [Thromboembolic disease (Rivaroxaban)]; Johnson and Johnson [Thromboembolic disease (Rivaroxaban)]; Pfizer [Thromboembolic disease (Apixaban)]; Portola [Thromboembolic disease (Andexanet)]."},{"name":"Margaret E Rick, MD","credentials":["Adjunct Clinical Professor of Medicine\n","Uniformed University of the Health Sciences, Bethesda, MD"],"disclosure":""},{"name":"David J Roberts, MA, MB, D Phil","credentials":["Professor of Hematology\n","Nuffield Dept of Clinical Laboratory Sciences, University of Oxford"],"disclosure":""},{"name":"Dario Roccatello, MD","credentials":["Professor of Nephrology and Clinical Pathology\n","University of Turin Medical School"],"disclosure":"Consultant/Advisory Boards: Genzyme [Eliglustat (Gaucher Disease)]."},{"name":"Richard J Rodeheffer, MD","credentials":["Professor of Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"Griffin P Rodgers, MD","credentials":["Chief, Molecular and Clinical Hematology Branch\n","National Institutes of Health"],"disclosure":""},{"name":"Zora R Rogers, MD","credentials":["Professor of Pediatrics\n","The University of Texas Southwestern Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Sickle cell disease]; Novartis [tpomimetic in acquired aplastic anemia]. Consultant/Advisory Board: Terumo BCT [medical monitor/DSMB member for PRAISE clinical trial (blood pathogen inactivation technology)]."},{"name":"Alain H Rook, MD","credentials":["Professor of Dermatology\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Soligenix [CTCL research (hypericin clinical trial)]; Medimmune [CTCL trial]; Galderma [CTCL trial]."},{"name":"Noel R Rose, MD, PhD","credentials":["Professor of Pathology\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Robert S Rosenson, MD","credentials":["Section Editor — Lipids\n","Professor of Medicine\n","Mount Sinai School of Medicine\n","Director, Cardiometabolic Disorders\n","Mount Sinai Heart"],"disclosure":"Grant/Research/Clinical Trial Support: Akcea [Lipids]; Amgen [Lipids (Evolocumab)]; Sanofi [Lipids (Alirocumab)]; AstraZeneca [Antiplatelets (Ticagrelor)]; The Medicines Company [Lipids (Inclisiran)]; Regeneron [Lipids (Evinocumab)]. Consultant/Advisory Boards: Akcea [Lipids]; Amgen [Lipids (Evolocumab)]; Regeneron [Lipids (Alirocumab)]; Sanofi [Lipids (Alirocumab)]; Akcea/Isis [Lipids]. Equity Ownership/Stock Options: MediMergent [Pharmacy claims database]. Other Financial Interests: Kowa [Lipids (Pitavastatin)] honorarium."},{"name":"David S Rosenthal, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Alan G Rosmarin, MD","credentials":["Deputy Editor — Hematology\n","Professor of Medicine\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Douglas S Ross, MD","credentials":["Section Editor — Thyroid Disease\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board: Medullary Thyroid Cancer Registry Consortium [Thyroid cancer]; Shire [Hypoparathyroidism (Parathyroid hormone for injection)]; Spectrix Therapeutics, LLC [Hypothyroidism (Thyroid hormone)]. Other Financial Interests: Abbott India (honorarium) [Hyperthyroidism (carbimazole, levothyroxine)]; Quest Diagnostics (honorarium) [Hyperthyroidism]."},{"name":"Brad H Rovin, MD","credentials":["Section Editor — Glomerular Diseases \n","Professor of Medicine and Pathology\n","The Ohio State University College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Glomerular Diseases/Molecular Interrogation of Kidney Biopsies, Precision Medicine/Biomarkers]. Consultant/Advisory Boards: Alexion [Lupus Nephritis (Eucluzimab)]; Aurinia [Lupus Nephritis, FSGS (Voclosporin)]; Biogen Idec [Lupus Nephritis (Anti-TWEAK)];  Biomarin [Hereditary Disorders of Metabolic Disorders (Pegvaliase)]; Bristol Myers Squibb [FSGS, MCD (Abatacept)]; Chemocentryx [Lupus Nephritis, ANCA Vasculitis, C3 Glomerulopathy (Avacopan)]; EMD Serono [IgA Nephropathy (Atacicept)]; Frazier Life Sciences [Lupus Nephritis]; Genentech [Lupus Nephritis, ANCA Vasculitis (Rituximab, Obinutuzumab)]; Lupus Foundation of America [Lupus Nephritis]; Mallinkrodt [Lupus Nephritis, FSGS (ACTHAR Gel)]; Medimmune [Lupus Nephritis (Anti-interferon)]; Novartis [IgA Nephropathy (Factor B Inhibitor)]; Pharmalink [IgA Nephropathy]; Retrophin [IgA Nephropathy (Sparsenten)]; Rigel [IgA Nephropathy (Fostamatinib])."},{"name":"Jayanta Roy-Chowdhury, MD, MRCP","credentials":["Professor of Medicine and Genetics\n","Albert Einstein College of Medicine"],"disclosure":""},{"name":"Namita Roy-Chowdhury, PhD","credentials":["Professor of Medicine and Genetics\n","Albert Einstein College of Medicine"],"disclosure":""},{"name":"James L Rubenstein, MD, PhD","credentials":["Professor of Medicine, Division of Hematology/Oncology\n","University of California, San Francisco"],"disclosure":"Grant/Research Support: Celgene [Lymphoma (Lenalidomide)]; Genentech [Lymphoma (Rituximab)]."},{"name":"Brenda M Sandmaier, MD","credentials":["Professor of Medicine, University of Washington\n","Member, Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"David T Scadden, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board: Fate [Stem cells]; Bone Therapeutics [Orthopedics]; FOG Pharma [cancer]; Magenta Therapeutics [stem cells]. Equity Ownership/Stock Options: Fate Therapeutics; Magenta Therapeutic; Clear Creek Bio; Agios Pharmaceuticals."},{"name":"Charles A Schiffer, MD","credentials":["Professor of Medicine and Oncology\n","Barbara Ann Karmanos Cancer Institute\n","Wayne State University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis, BMS, Ariad [CML (imatinib, nilotinib, dasatinib, ponatinib)]. Consultant/Advisory Boards: Celgene [AML, thrombotic complications (5-azacytidine, lenalidomide)]; Pfizer [CML (bosutinib)]; Takeda; Ambit; Pharmacyclics; Juno; Astellas [DSMB thrombotic complications]."},{"name":"Stanley L Schrier, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Myeloproliferative Disorders; Red Blood Cell Disorders\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Iris Schrijver, MD","credentials":["Adjunct Professor of Pathology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Peter H Schur, MD","credentials":["Editor-in-Chief — Rheumatology\n","Section Editor — Basic Science\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Sanjeev Sethi, MD, PhD","credentials":["Professor of Laboratory Medicine and Pathology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Neeral L Shah, MD","credentials":["Associate Professor, Division of Gastroenterology and Hepatology\n","University of Virginia"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead [hepatitis C]. Consultant/Advisory Boards: Dova Pharmaceuticals [(thrombopoietin agonists)]."},{"name":"Elizabeth Shane, MD","credentials":["Professor of Medicine\n","Columbia University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Osteoporosis (denosumab)]. Consultant/Advisory Boards: Amgen [Osteoporosis (denosumab)]."},{"name":"Amy D Shapiro, MD","credentials":["Medical Director\n","Indiana Hemophilia and Thrombosis Center\n","Adjunct Professor of Pediatrics\n","Michigan State University"],"disclosure":"Grant/Research Support: Shire [Bleeding disorders (Antihemophilic factor, anti-inhibitor coagulant complex, vapor heated)]; Daiichi Sankyo; Kedrion Biopharma [Bleeding disorders (Topical ophthalmologic plasminogen concentrate)]; OPKO; [Bleeding disorders (IV long-acting recombinant factor VIIa concentrate)]; ProMetic Life Sciences [Bleeding disorders (IV plasminogen concentrate)]; Bioverativ[Bleeding disorders (Antihemophilic factor [recombinant], coagulation factor IX [recombinant])]; Genentech [Bleeding disorders (Emicizumab-kxwh)]; Novo Nordisk [Bleeding disorders (Coagulant factor VIIA [recombinant], anti-TFP therapeutic antibody)]; Octapharma [Bleeding disorders (Antihemophilic factor [recombinant])]. Consultant/Advisory Boards: Shire [Bleeding disorders (Antihemophilic factor, anti-inhibitor coagulant complex, vapor heated)]; Novo Nordisk [Bleeding disorders (Coagulant factor VIIA [recombinant])]; Novo Nordisk Hemophilia Foundation [Hemophilia]; Bayer Healthcare Pharmaceuticals [Pediatric hemophilia (Antihemophilic factor [recombinant])]; Bioverativ [Bleeding disorders (Antihemophilic factor [recombinant],  coagulation factor IX [recombinant])]; Genentech [Bleeding disorders (Emicizumab-kxwh)]; ProMetic Life Sciences; Kedrion Biopharma; Sangamo Biosciences [Bleeding disorders]; Bio Products Laboratory [Bleeding disorders (Coagulation factor X [human])]. Employment: American Thrombosis and Hemostasis Network [Medical Director - National Hemophilia Program Coordinating Center]."},{"name":"Robert H Shmerling, MD","credentials":["Section Editor — Diagnostic Issues in Rheumatology\n","Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board: Knowyourmeds [Advise on matters relating to the Company’s business, technology and products (medication information)]."},{"name":"Claire Shovlin, PhD, FRCP","credentials":["Reader in Clinical and Molecular Medicine, NHLI Cardiovascular Sciences\n","Imperial College, London"],"disclosure":"Grant/Research/Clinical Trial Support: US Department of Defense [Stopping the Stops in HHT]. Speaker's Bureau: European Respiratory Society [Pulmonary Arteriovenous Malformations (Meet the Expert Lecture)]. Consultant/Advisory Boards: Vernalis [HHT]."},{"name":"Colin A Sieff, MB, BCh, FRCPath","credentials":["Associate Professor of Pediatrics\n","Boston Children's Hospital"],"disclosure":""},{"name":"Arthur J Silvergleid, MD","credentials":["Section Editor — Transfusion Medicine\n","Affiliate Associate Professor, Department of Pathology and Cell Biology\n","University of South Florida, College of Medicine\n","Medical Director, OneBlood, Inc."],"disclosure":""},{"name":"Ashwani K Singal, MD, MS","credentials":["Associate Professor, Division of Gastroenterology and Hepatology\n","University of Alabama at Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: NIH, ACG [Porphyria, alcoholic liver disease]; Gilead Sciences, Aurora Pharmaceuticals [Alcoholic steatohepatitis, nonalcoholic steatohepatitis]; Alnylam Pharmaceuticals [Porphyria]. Consultant/Advisory Boards: Recordati [Porphyria (Hemin)]; Alnylam [siRNA for ALAS-1]; Gilead Sciences [Hepatitis B virus, Hepatitis C virus, nonalcoholic steatohepatitis]; Alexion Pharmaceuticals [Fatty liver disease]. Employment: UAB."},{"name":"Daniel H Solomon, MD, MPH","credentials":["Matthew H. Liang Distinguished Chair in Arthritis and Population Health\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Rheumatoid arthritis (Celecoxib)]."},{"name":"Michael J Somers, MD","credentials":["Associate Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Gagan K Sood, MD","credentials":["Associate Professor, Department of Surgery and Medicine\n","Baylor College of Medicine"],"disclosure":""},{"name":"David P Steensma, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Celgene [MDS (Lenalidomide, azacitidine)]; Janssen [AML (Experimental agent)]; Takada/Millennium [MDS (None)]; Tesaro [MDS (None)]; Otsuka [MDS (Decitabine)]; Acceleron [MDS (Experimental agent)]; H3 Biosciences [MDS (Experimental agent)]."},{"name":"Martin H Steinberg, MD","credentials":["Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine\n","Boston University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: MyoSyntax [(High-throughput HbF diagnostic)]; Incyte [(Cellular studies of LSD inhibitors for HbF induction)]. Consultant/Advisory Boards: Sancillio Therapeutics. Equity Ownership/Stock Options: Vanguard Therapeutics."},{"name":"Richard H Sterns, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Professor Emeritus\n","University of Rochester School of Medicine and Dentistry"],"disclosure":""},{"name":"C Philip Steuber, MD","credentials":["Professor of Pediatric Hematology and Oncology\n","Baylor College of Medicine"],"disclosure":""},{"name":"E Richard Stiehm, MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Immunology and Immunodeficiency\n","Distinguished Research Professor of Pediatrics\n","David Geffen School of Medicine at UCLA"],"disclosure":"Consultant/Advisory Boards: ADMA Biologics [Infections of respiratory syncytial virus in organ transplants (Respiratory syncytial virus immune globulin)]."},{"name":"Stephan Stilgenbauer, MD","credentials":["Professor of Medicine\n","Ulm University"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie (CLL, NHL [venetoclax]); Amgen (CLL, NHL [blinatumumab]); Boehringer-Ingelheim (CLL, NHL); Celgene (CLL, NHL [lenalidomide]); Genentech (CLL, NHL [venetoclax, rituximab, obinutuzumab]); Genzyme (CLL, NHL [alemtuzumab]); Gilead (CLL, NHL [idelalisib]); GSK (CLL, NHL); Janssen (CLL, NHL [ibrutinib]); Mundipharma (CLL, NHL [bendamustine]); Novartis (CLL, NHL); Pharmacyclics (CLL, NHL[ibrutinib]); Roche (CLL, NHL [venetoclax, rituximab, obinutuzumab]). Consultant/Advisory Boards: AbbVie (CLL, NHL [venetoclax]); Amgen (CLL, NHL [blinatumumab]); Boehringer-Ingelheim (CLL, NHL); Celgene (CLL, NHL [lenalidomide]); Genentech (CLL, NHL [venetoclax, rituximab, obinutuzumab]); Genzyme (CLL, NHL [alemtuzumab]); Gilead (CLL, NHL [idelalisib]); GSK (CLL, NHL); Janssen (CLL, NHL [ibrutinib]); Mundipharma (CLL, NHL [bendamustine]); Novartis (CLL, NHL); Pharmacyclics (CLL, NHL[ibrutinib]); Roche (CLL, NHL [venetoclax, rituximab, obinutuzumab])."},{"name":"Wendy Stock, MD","credentials":["Professor of Medicine\n","Pritzker School of Medicine of the University of Chicago"],"disclosure":"Consultant/Advisory Boards: Pfizer [ALL (Inotuzumab)]; Jazz [ALL (Erwinia asparaginase)]; Astellas [AML (Gilteritinib)]."},{"name":"Richard M Stone, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis. Consultant/Advisory Boards: Abbvie, Agios, Amgen, Celator, Celgene, Novartis, Pfizer, Jazz, FujiFilm, Ono, Orsenix."},{"name":"Michael Stowasser, MD","credentials":["Director\n","Endocrine Hypertension Research Centre, University of Queensland Diamantina Institute\n","Greenslopes and Princess Alexandra Hospitals, Brisbane, Australia"],"disclosure":""},{"name":"Jason R Stubbs, MD","credentials":["Associate Professor of Medicine\n","Division of Nephrology & Hypertension\n","University of Kansas Medical Center"],"disclosure":""},{"name":"Martin I Surks, MD","credentials":["Professor of Medicine and Pathology\n","Albert Einstein College of Medicine"],"disclosure":""},{"name":"Ritsuro Suzuki, MD, PhD","credentials":["Associate Professor, Department of Oncology and Hematology\n","Shimane University Hospital Cancer Center"],"disclosure":"Speaker's Bureau: Kyowa-Kirin [lymphoma (L-asparaginase)]."},{"name":"Harold Szerlip, MD, FACP, FCCP, FASN, FNKF","credentials":["Director, Nephrology Division, Baylor University Medical Center, Dallas\n","Program Director, Nephrology Training Program, Baylor University Medical Center\n","Clinical Professor of Medicine, Texas A&M College of Medicine\n","Adjunct Professor of Medicine, Texas College of Osteopathic Medicine"],"disclosure":""},{"name":"Martin S Tallman, MD","credentials":["Chief, Leukemia Service, Memorial Sloan-Kettering Cancer Center\n","Professor of Medicine\n","Weill Cornell Medical College"],"disclosure":""},{"name":"Udaya S Tantry, PhD","credentials":["Laboratory Director\n","Thrombosis Research Lab, \n","Inova Heart and Vascular Institute"],"disclosure":"Consultant/Advisory Boards: AstraZeneca [Coronary artery disease (Ticagrelor)]; Medicure [Coronary artery disease, percutaneous intervention, and GPIIb/IIIa inhibitors]."},{"name":"Katherine Tarlock, MD","credentials":["Research Associate\n","Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"Ayalew Tefferi, MD","credentials":["Professor of Medicine and Hematology\n","Mayo Medical School"],"disclosure":""},{"name":"Amanda M Termuhlen, MD","credentials":["Professor of Clinical Pediatrics\n","Keck School of Medicine, University of Southern California"],"disclosure":""},{"name":"Swee Lay Thein, MD, FRCP, FRCPath, DSc","credentials":["Chief, Sickle Cell Branch\n","National Heart, Lung and Blood Institute\n","The National Institutes of Health"],"disclosure":""},{"name":"Arthur C Theodore, MD","credentials":["Associate Professor of Medicine\n","Boston University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Mycophenolate (Scleroderma, Interstitial lung disease)]."},{"name":"Michael J Thirman, MD","credentials":["Associate Professor of Medicine\n","Pritzker School of Medicine of the University of Chicago"],"disclosure":""},{"name":"Jennifer S Tirnauer, MD","credentials":["Deputy Editor — Hematology"],"disclosure":""},{"name":"Marsha J Treadwell, PhD","credentials":["Clinical Scientist\n","Northern California Comprehensive Sickle Cell Center\n","Department of Hematology/Oncology\n","UCSF Benioff Children's Hospital Oakland"],"disclosure":""},{"name":"R Michael Tuttle, MD","credentials":["Professor of Medicine\n","Memorial Sloan Kettering Cancer Center"],"disclosure":"Grant/Research Support: AstraZeneca [Thyroid cancer (Selumetinib)]. Consultant/Advisory Boards: Bayer/Onyx [Thyroid cancer (Sorafenib)]; Eisai [Thyroid cancer (Lenvatinib)]; Genzyme/Sanofi [Thyroid cancer (Recombinant human TSH)]; Novo Nordisk [Thyroid cancer (Liraglutide)]; Roche [Thyroid cancer (Thyroglobulin assay)]; Veracyte [Thyroid cancer (Gene testing)]."},{"name":"Lynne Uhl, MD","credentials":["Associate Professor of Pathology\n","Harvard Medical School"],"disclosure":""},{"name":"Marcel RM van den Brink, MD, PhD","credentials":["Head, Division of Hematologic Oncology\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Seres. Consultant/Advisory Boards: Evelo."},{"name":"Richard A Van Etten, MD, PhD","credentials":["Professor of Medicine\n","University of California, Irvine"],"disclosure":""},{"name":"Astrid van Tubergen, MD, PhD","credentials":["Rheumatologist\n","Maastricht University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Spondyloarthritis (Etanercept)]; AbbVie [Spondyloarthritis (Adalimumab)]; UCB [Spondyloarthritis (Certolizumab)]; Jansen-Cilag [Psoriatic arthritis (Ustekinumab)]; Celgene [Psoriatic arthritis (Apremilast)]; MSD [Spondyloarthritis (Infliximab, golimumab)]; Novartis [Spondyloarthritis (Secukinumab)]. Consultant/Advisory Board: Jansen-Cilag [Psoriatic arthritis (Ustekinumab)]; Novartis [Spondyloarthritis (Secukinumab)]."},{"name":"John Varga, MD","credentials":["John and Nancy Hughes Professor of Medicine\n","Northwestern University Feinberg School of Medicine"],"disclosure":""},{"name":"Sara R Vazquez, PharmD, BCPS, CACP","credentials":["Clinical Pharmacist\n","University of Utah Health"],"disclosure":""},{"name":"John Vella, MD, FACP, FRCP, FASN, FAST","credentials":["Associate Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas; Bristol Myers Squibb [Transplantation (CMV vaccine, belatacept)]."},{"name":"Vijaya M Vemulakonda, MD, JD","credentials":["Associate Professor, Pediatric Urology\n","University of Colorado School of Medicine"],"disclosure":""},{"name":"Sebastien Viatte, MD, PhD","credentials":["Lecturer in Genetics\n","Arthritis Research UK Centre for Genetics and Genomics\n","The University of Manchester, UK"],"disclosure":""},{"name":"Elliott P Vichinsky, MD","credentials":["Adjunct Professor\n","University of California San Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [iron chelation (deferasirox)]; ApoPharma [iron chelation (deferiprone)]."},{"name":"Demetrios V Vlahakos, MD","credentials":["Professor of Medicine and Nephrology, Director, Renal Unit \n","Attikon University Hospital \n","Athens University School of Medicine\n","National and Kapodistrian University of Athens"],"disclosure":""},{"name":"Ron Wald, MDCM, MPH, FRCPC","credentials":["Associate Professor, Department of Medicine \n","University of Toronto"],"disclosure":""},{"name":"Dawn Ward, MD","credentials":["Assistant Professor, Division of Transfusion Medicine \n","David Geffen School of Medicine at UCLA"],"disclosure":""},{"name":"Steven E Weinberger, MD","credentials":["Adjunct Professor of Medicine\n","University of Pennsylvania School of Medicine\n","Executive Vice President and CEO Emeritus\n","American College of Physicians"],"disclosure":""},{"name":"Melvin P Weinstein, MD","credentials":["Professor of Medicine and Pathology\n","Robert Wood Johnson Medical School"],"disclosure":""},{"name":"Jeffrey Weitz, MD","credentials":["Professor of Medicine and Biochemistry\n","McMaster University"],"disclosure":"Consultant/Advisory Boards: Boehringer-Ingelheim [anticoagulation (dabigatran, idarucizumab)]; Bayer/Janssen [anticoagulation (rivaroxaban)]; Bristol Myers Squibb/Pfizer [anticoagulation (apixaban)]; Daiichi-Sankyo [anticoagulation (edoxaban)]; Portola [anticoagulation (andexanet)]; Ionis Pharmaceuticals, Merck, Novartis, Pfizer [anticoagulation]."},{"name":"Peter F Weller, MD, MACP","credentials":["Editor-in-Chief — Infectious Diseases\n","Section Editor — Tropical Medicine\n","William Bosworth Castle Professor of Medicine\n","Harvard Medical School\n","Professor of Immunology and Infectious Diseases\n","Harvard T. H. Chan School of Public Health"],"disclosure":"Grant/Research/Clinical Trial Support: GlaxoSmithKline [Anti-IL5 mAb for EGPA (Mepolizumab)]."},{"name":"Patrick Y Wen, MD","credentials":["Section Editor — Neurooncology\n","Professor of Neurology\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Acerta [Brain tumor (ACP196); Agios [Brain tumor (AG120, AG881); Angiochem [Brain tumor (ANG1005); AstraZeneca [Brain tumor (Vandetanib)]; Kadmon [Brain tumor 9tesevatinib); Karyopharm [Brain tumor (Selinexor)]; Merck [Brain tumor (Pembrolizumab)]; Novartis [Brain tumor (Trametanib, dabrafenib, BGJ398, INC208)]; Oncoceutics [Brain tumor (ONC201)]; Vascular Biogenics [Brain tumor (VB111)]; Roche [Brain tumor (Bevacizumab)]; Sanofi-Aventis [Brain tumor (Plerixafor)]. Speaker's Bureau: Merck [Brain tumor]. Consultant/Advisory Boards: Agios [Brain tumor (AG120)]; Astra Zeneca [Brain tumor]; Cavion [Brain tumor (Mibefradil)]; Cortice Biosciences [Brain tumor (TP12887)]; Foundation Medicine [Brain tumor (none)]; Genentech/Roche [Brain tumor (Bevacizumab)]; Monteris [Brain tumor (Neuroblate)]; Novartis [Brain tumor (LDK298)]; Novogen [Brain tumor (GDC0084); Regeneron [Brain tumor (PD1 antibodies)]; Vascular Biogenics [Brain tumor (VB111)]; VBI Vaccines [Brain tumors]."},{"name":"Eelco FM Wijdicks, MD","credentials":["Professor of Neurology\n","Mayo Medical School"],"disclosure":""},{"name":"Rein Willemze, MD","credentials":["Professor and Chairman, Department of Dermatology\n","Leiden University Medical Center"],"disclosure":""},{"name":"John R Wingard, MD","credentials":["Professor of Medicine\n","University of Florida College of Medicine"],"disclosure":"Consultant/Advisory Boards: Astellas [CMV, antifungal drugs]; Ansun, Gilead [respiratory virus antivirals]; Merck [CMV, antifungal drugs, vaccine]; Shire [CMV antiviral drug]; Fate Therapeutics [Cell product]; Celgene [CAR T-cell product]."},{"name":"Joachim Yahalom, MD","credentials":["Member and Professor of Radiation Oncology\n","Memorial Sloan-Kettering Cancer Center \n","Cornell University Weill College of Medicine"],"disclosure":""},{"name":"Motoko Yamaguchi, MD, PhD","credentials":["Assistant Professor, Department of Hematology and Oncology\n","Mie University Graduate School of Medicine"],"disclosure":""},{"name":"Amber M Yates, MD","credentials":["Assistant Professor of Pediatrics\n","Baylor College of Medicine"],"disclosure":""},{"name":"Leman Yel, MD","credentials":["Associate Professor Emeritus of Clinical Medicine\n","University of California"],"disclosure":"Employment: Shire Plc [Immunology] - No relevant conflict on topic. Equity Ownership/Stock Options: Shire Plc."},{"name":"William F Young, Jr, MD, MSc","credentials":["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Consultant/Advisory Boards: Nihon Medi-Physics Co, Ltd [Primary aldosteronism (Novel PET-based adrenal imaging)]."},{"name":"Alan S L Yu, MB, BChir","credentials":["Harry Statland and Solon Summerfield Professor of Medicine\n","University of Kansas Medical Center"],"disclosure":""},{"name":"David T Yu, MD","credentials":["Emeritus Professor\n","University of California Los Angeles"],"disclosure":""},{"name":"Shan Yuan, MD","credentials":["Associate Professor\n","City of Hope"],"disclosure":""},{"name":"Dana Zappetti, MD","credentials":["Assistant Professor of Medicine \n","Weill Cornell Medical College"],"disclosure":""},{"name":"James L Zehnder, MD","credentials":["Professor of Pathology and Medicine (Hematology)\n","Stanford University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Novo Nordisk [Hemostasis testing methods]; Novartis [Thrombopoietin agonists (Eltrombopag)]; Instrumentation Laboratory [laboratory instrumentation (hemostasis testing methods)]."},{"name":"Yanming Zhang, MD","credentials":["Attending\n","Director of Cytogenetics Laboratory\n","Memorial Sloan Kettering Cancer Center"],"disclosure":""},{"name":"Jeffrey Zonder, MD","credentials":["Professor of Medicine and Oncology\n","Barbara Ann Karmanos Cancer Institute\n","Wayne State University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [amyloidosis (lenalidomide, thalidomide, pomalidomide [IMiDs])]. Consultant/Advisory Boards: Celgene [myeloma, amyloidosis (IMiDs)]; Janssen [myeloma, amyloidosis (daratumumab)]; BMS [myeloma, amyloidosis (elotuzumab)]; Seattle Genetics [myeloma, amyloidosis (investigational mAb)]; Takeda [myeloma, amyloidosis (bortezomib, Ixazomib)]; Prothena [myeloma, amyloidosis (NEOD001)]; Amgen [myeloma, amyloidosis (carfilzomib)]. Other Financial Interest (contributor and spouse): \tMMRF travel grant supported by Takeda and CURE magazine [Moving Mountains for Multiple Myeloma Fundraising team for the MMRF]."},{"name":"Stéphane Zuily, MD, MPH, PhD","credentials":["Associate Professor of Medicine, Nancy School of Medicine of Lorraine University\n","Attending Physician, Vascular Medicine Division, Nancy Academic Hospital"],"disclosure":""}]},{"name":"Peer Reviewers","contributors":[{"name":"Michael Auerbach, MD, FACP","credentials":["Clinical Professor of Medicine\n","Georgetown University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AMAG Pharmaceuticals; Pharmacosmos [Restless legs syndrome, iron deficiency of pregnancy (Ferumoxytol, low molecular weight iron dextran)]. Consultant/Advisory Boards: AMAG; Pharmacosmos; Luitpold/American Regent [Moderate to severe iron deficiency (Low molecular weight iron dextran)]."},{"name":"Joel S Bennett, MD","credentials":["Professor of Medicine, Hematology-Oncology Division\n","University of Pennsylvania"],"disclosure":""},{"name":"Herbert L Bonkovsky, MD","credentials":["Adjunct Professor, University of North Carolina\n","Professor, University of Connecticut"],"disclosure":"Grant/Research/Clinical Trial Support: Alnylam Pharma [acute hepatic porphyrias (Givosiran)]; Gilead Sciences [PCT HCV (Harvoni)]; Recordati; Mitsubishi Tanabe [Porphyria (hematin)]. Consultant/Advisory Boards: Alnylam Pharma [acute hepatic porphyrias (Givosiran)]; Recordati [acute hepatic porphyrias (Panhematin)]; Mitsubishi Tanabe [Porphyria (hematin)]; Moderna [acute hepatic porphyrias (Investigational agent not yet named)];  Stoke Pharma [porphyrias (Possible investigational agents not yet named)]."},{"name":"Robert M Bookchin, MD","credentials":["Professor of Medicine\n","Albert Einstein College of Medicine"],"disclosure":"Consultant/Advisory Boards: Social Security Administration. Equity Ownership/Stock Options: Gilead; Pfizer; CVS; Celgene; Ionis; McKesson. Equity Ownership/Stock Options (Spouse): JT Pharma."},{"name":"Mark Bower, PhD, FRCP, FRCPath","credentials":["Professor of Oncology\n","Imperial College, London"],"disclosure":"Speaker's Bureau: ViiV, Gilead, MSD, Janssen [HIV-related cancers (siltuximab, rituximab)]."},{"name":"Patrick Brown, MD","credentials":["Director, Pediatric Leukemia Program\n","Associate Professor of Oncology and Pediatrics\n","Sidney Kimmel Comprehensive Cancer Center\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Carlo Brugnara, MD","credentials":["Professor\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Pfizer [sickle cell anemia (senicapoc)]."},{"name":"Jorge J Castillo, MD","credentials":["Assistant Professor, Harvard Medical School\n","Bing Center for Waldenstrom Marcoglobulinemia\n","Dana-Farber Cancer Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie [WM (venetoclax)], Millennium [WM (ixazomib)]. Consultant/Advisory Boards: Janssen Latin America [myeloma (ibrutinib)]."},{"name":"Joel Anne Chasis, MD","credentials":["Associate Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Joseph M Connors, MD","credentials":["Chair, Lymphoma Tumor Group\n","British Colombia Cancer Agency"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen, Bayer, Bristol Myers-Squibb, Cephalon, F Hoffman-La Roche, Genentech, Janssen, Lilly, Merck, NanoString Technologies, Seattle Genetics, Takeda [lymphoma treatment (multiple pharmaceutical products)]. Patent Holder: NanoString Technologies."},{"name":"Claire Dearden, MD, BSc, FRCP, FRCPath","credentials":["Consultant Haematologist\n","The Royal Marsden Hospital and Institute of Cancer Research, London"],"disclosure":"Consultant/Advisory Boards: Roche [B-PLL (Rituximab)]; Gilead [B-PLL (Idelalisib)]; Janssen [B-PLL (Ibrutinib)]; Sanofi [T-PLL (Alemtuzumab)]."},{"name":"Michael R DeBaun, MD, MPH","credentials":["Professor of Pediatrics and Internal Medicine\n","Vanderbilt University School of Medicine"],"disclosure":""},{"name":"Robert J Desnick, MD, PhD","credentials":["Professor and Chair, Department of Genetics and Genomic Sciences\n","Mount Sinai School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Alnylam [Acute porphyria (RNAi therapy clinical trial)]; Recordati Rare Diseases. Consultant/Advisory Boards: Alnylam [Acute porphyria (RNAi therapy clinical trial)]; Recordati Rare Diseases. Patent Holder: Alnylam [Acute porphyria (RNAi therapy clinical trial)]."},{"name":"Jonathan W Friedberg, MD","credentials":["Professor of Medicine\n","James P Wilmot Cancer Center, University of Rochester"],"disclosure":"Consultant/Advisory Boards: Bayer [DSMB for trials (Investigational agents)]; Astellas [DSMB for trials (Acalabrutinib)]."},{"name":"Richard R Gammon, MD","credentials":["Medical Director - OneBlood, Inc.\n","Assistant Professor of Pathology, University of Central Florida, College of Medicine"],"disclosure":""},{"name":"Tomas Ganz, MD, PhD","credentials":["Professor of Medicine and Pathology\n","David Geffen School of Medicine at UCLA"],"disclosure":"Grant/Research/Clinical Trial Support: Keryx Pharma [Iron metabolism (Iron Citrate)], Silarus Pharma [Iron metabolism], Akebia [Anemia and iron metabolism]. Consultant/Advisory Boards: Akebia, Vifor Pharma, Intrinsic LifeSciences, La Jolla Pharmaceutical Company, Keryx Pharma, Silarus Pharma [iron metabolism and anemia (IV iron, Iron diagnostics, Minihepcidin, Iron citrate)]. Patent Holder: Multiple assigned to UCLA [Iron metabolism]. Equity Ownership/Stock Options: Intrinsic LifeSciences, Silarus Pharma."},{"name":"Jason Gotlib, MD, MS","credentials":["Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Mastocytosis (Midostaurin)]; NIH/NCI [Advanced systemic mastocytosis/mast cell leukemia (Brentuximab vedotin)]; NIH/NCI [Systemic mastocytosis (Ibrutinib)]; Seattle Genetics [Advanced systemic mastocytosis/mast cell leukemia (Brentuximab vedotin)]; Pharmacyclics [Systemic mastocytosis (Ibrutinib)]; Stemline Therapeutics, Inc [High-risk myeloproliferative neoplasms (SL-401)]. Consultant/Advisory Boards: Deciphera Pharmaceuticals [Mastocytosis]; Blueprint Medicines [Mastocytosis]; Plexxikon [Mastocytosis]."},{"name":"Lawrence D Kaplan, MD","credentials":["Clinical Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Youn H Kim, MD","credentials":["Professor of Dermatology\n","Stanford University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Esai [CTCL (E7777/denileukin diftitox)], Kyowa Hakko Kirin [CTCL (mogamulizumab)], Merck [CTCL (Pembromulizumab)], Millennium/Takeda [CTCL (brentuximab vedotin)], Seattle Genetics [CTCL (brentuximab vedotin)], Soligenix [CTCL (TOPICAL SGX301)], Tetralogic [CTCL (SHAPE)], Neumedicine [CTCL (Interleukin-12)], Innate [CTCL (IPH4102)], Infinity Pharmaceuticals. Consultant/Advisory Boards: Actelion [CTCL], Celgene [CTCL (Romidepsin)], Eisai [CTCL (E7777/denileukin diftitox)], Galderma [CTCL], Kyowa Hakko Kirin [CTCL (Mogamulizumab)], Millennium/Takeda Pharma [CTCL (Brentuximab Vedotin)], Seattle Genetics [CTCL (Brentuximab Vedotin)], Forty Seven Inc [CTCL], Horizon Pharma [CTCL (Actimmune)], Portola Pharma [CTCL (Cerdulatinib)], miRagen [CTCL (AntimiR-155 MRG-106)], Medivir."},{"name":"Jonathan E Kolitz, MD","credentials":["Professor of Medicine\n","Hofstra Northwell School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Celator [AML (CPX-351)]; Boehringer-Ingelheim [AML (volasertib, BI836858)]; Millennium [AML, MDS (pevonedistat)]; Cantex [AML (CX-01)]; Erytech Pharma [ALL (ERYASP)]. Consultant/Advisory Boards: Pharmacyclics, Seattle Genetics, Novartis, Gilead."},{"name":"Marcel Levi, MD, PhD","credentials":["Chief Executive Officer\n","University College London Hospitals\n","Professor of Medicine\n","Academic Medical Center, University of Amsterdam"],"disclosure":""},{"name":"Raymond Liang, MD","credentials":["SH Ho Professor of Hematology and Oncology\n","University of Hong Kong"],"disclosure":""},{"name":"Andrew Lister, MD, FRCP, FRCPath, FRCR","credentials":["Section Editor — Lymphoproliferative Disorders\n","Professor of Medical Oncology\n","St. Bartholomew's Hospital, London"],"disclosure":"Consultant/Advisory Boards: Celgene [malignant lymphoma], Pfizer [Lymphoma (anti-CD20 biosimilars)], Gilead (data monitoring committee) [CLL, indolent lymphoma (idelalisib [CAL 101])], Roche (data monitoring committee) [Indolent lymphoma (obinutuzumab [GA101])], Millennium/Takeda (data monitoring committee) [Hodgkin lymphoma (brentuximab vedotin)]; Merck (pembrolizumab). Equity Ownership/Stock Options (Spouse also): GSK; Johnson & Johnson; AstraZeneca; Novartis; Pfizer; Hikma Pharma."},{"name":"Thomas P Loughran, Jr, MD","credentials":["Director, University of Virginia Cancer Center\n","University of Virginia"],"disclosure":""},{"name":"Silvia Montoto, MD","credentials":["Senior Lecturer, Honorary Consultant\n","Barts and The London School of Medicine and Dentistry"],"disclosure":"Speaker's Bureau: Roche [NHL (rituximab)]. Other Financial Interest: Gilead [travel support, NHL (idelalisib)]."},{"name":"Lori Muffly, MD, MS","credentials":["Assistant Professor of Medicine\n","Blood and Marrow Transplantation\n","Stanford University"],"disclosure":""},{"name":"Anupama Narla, MD","credentials":["Assistant Professor of Pediatrics (Hematology/Oncology)\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Peter Newburger, MD","credentials":["Section Editor — White Blood Cell Disorders\n","Ali and John Pierce Professor of Pediatric Hematology/Oncology\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Enrico M Novelli, MD, MS","credentials":["Assistant Professor of Medicine, University of Pittsburgh\n","Medical Director, UPMC Adult Sickle Cell Anemia Program"],"disclosure":""},{"name":"Ruth F Padmore, MD, FRCPC, PhD","credentials":["Staff Hematopathologist, The Ottawa Hospital and Eastern Ontario Regional Laboratory Association\n","Associate Professor, University of Ottawa"],"disclosure":""},{"name":"German A Pihan, MD","credentials":["Chief Diagnostic Hematopathology Service, Beth Israel Deaconess Medical Center\n","Assistant Professor of Pathology, Harvard Medical School"],"disclosure":""},{"name":"Josef T Prchal, MD","credentials":["Professor of Medicine\n","University of Utah"],"disclosure":""},{"name":"Andreas Rosenwald, MD","credentials":["Professor, Institute of Pathology\n","University of Würzburg, Germany"],"disclosure":""},{"name":"Mohammed Salhab, MD","credentials":["Hematology/Oncology Fellow\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Vaishali Sanchorawala, MD","credentials":["Professor of Medicine\n","Director, Autologous Stem Cell Transplant Program\n","Director, Amyloidosis Center\n","Boston Medical Center and Boston University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Prothena [AL amyloidosis (NEOD001)], Takeda [AL amyloidosis (ixazomib)]. Consultant/Advisory Boards: Caelum [AL amyloidosis (11-1F4)]."},{"name":"Stanley L Schrier, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Myeloproliferative Disorders; Red Blood Cell Disorders\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Detlef Schuppan, MD, PhD","credentials":["Professor of Medicine, Harvard Medical School\n","Institute for Translational Immunology\n","Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany, Division of Gastroenterology"],"disclosure":"Patent Holder: Eurospital [Celiac disease (TG2-antibody)]. Consultant/Advisory Boards: Takeda [Celiac disease (Celiac disease drug development)]."},{"name":"Arthur J Silvergleid, MD","credentials":["Section Editor — Transfusion Medicine\n","Affiliate Associate Professor, Department of Pathology and Cell Biology\n","University of South Florida, College of Medicine\n","Medical Director, OneBlood, Inc."],"disclosure":""},{"name":"Martin S Tallman, MD","credentials":["Chief, Leukemia Service, Memorial Sloan-Kettering Cancer Center\n","Professor of Medicine\n","Weill Cornell Medical College"],"disclosure":""},{"name":"Douglas M Tollefsen, MD","credentials":["Professor of Medicine\n","Washington University School of Medicine"],"disclosure":""},{"name":"Guido J Tricot, MD, PhD","credentials":["Professor of Medicine, Director of BMT and Myeloma Program\n","University of Iowa"],"disclosure":""},{"name":"Richard A Van Etten, MD, PhD","credentials":["Professor of Medicine\n","University of California, Irvine"],"disclosure":""},{"name":"Michael R Verneris, MD","credentials":["Professor of Pediatrics, University of Colorado School of Medicine\n","Director of Bone Marrow Transplantation and Cellular Therapy\n","The Barton Family Endowed Chair of Bone Marrow Transplant"],"disclosure":"Consultant/Advisory Boards: B-MoGen; Fate Therapeutics [Natural killer cell therapy]. Equity Ownership/Stock Options: B-MoGen; Fate Therapeutics."},{"name":"Ravi Vij, MD, MBA","credentials":["Professor of Medicine\n","Washington University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen, Takeda [multiple myeloma]. Consultant/Advisory Boards: Celgene, Takeda, BMS, Janssen, Abbvie, Amgen, Karyopharm [multiple myeloma]."},{"name":"John R Wingard, MD","credentials":["Professor of Medicine\n","University of Florida College of Medicine"],"disclosure":"Consultant/Advisory Boards: Astellas [CMV, antifungal drugs]; Ansun, Gilead [respiratory virus antivirals]; Merck [CMV, antifungal drugs, vaccine]; Shire [CMV antiviral drug]; Fate Therapeutics [Cell product]; Celgene [CAR T-cell product]."},{"name":"Ann K Wittkowsky, PharmD, CACP, FASHP, FCCP","credentials":["Clinical Professor \n","University of Washington School of Pharmacy"],"disclosure":""},{"name":"Yanyun Wu, MD, PhD","credentials":["Chief Medical Officer\n","Puget Sound Blood Center"],"disclosure":""},{"name":"James L Zehnder, MD","credentials":["Professor of Pathology and Medicine (Hematology)\n","Stanford University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Novo Nordisk [Hemostasis testing methods]; Novartis [Thrombopoietin agonists (Eltrombopag)]; Instrumentation Laboratory [laboratory instrumentation (hemostasis testing methods)]."}]}]}